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RESUMO 
Nos últimos anos, as células estaminais mesenquimais (CEM’s) têm sido foco de interesse na 
comunidade científica devido à sua capacidade de diferenciação em diferentes linhagens celulares, 
tais como adipócitos, osteoblastos e condrócitos. Neste trabalho, CEM’s humanas foram combinadas 
com poli(fluoreto de vinilideno), PVDF, um polímero piezoelétrico biocompatível, de modo a 
impulsionar a sua expansão e proliferação in vitro, com o objetivo principal de obter um substancial 
número de células com fenótipo osteoblástico para regeneração de tecidos. 
Com este propósito, filmes de PVDF em fase α foram submetidos a electrospray com 
diferentes tempos de deposição, dando origem a dois substratos, com alta e baixa concentração de 
micropartículas de β-PVDF. Foram também produzidas micropartículas sem substrato com vista a 
criar um ambiente 3D e filmes planos de β-PVDF foram usados como referência. Antes do cultivo 
celular, os marcadores superficiais celulares característicos de CEM’s (CD105, CD90 e CD73) foram 
analisados por citometria de fluxo (CF). Quatro dias depois de serem cultivadas nos biomateriais, a 
viabilidade celular foi examinada. Em paralelo, CF, microscopia eletrónica de varrimento (MEV) e 
ensaios de imunocitoquímica de vinculina foram realizados de modo a avaliar a manutenção da 
multipotencialidade das CEM’s e a sua morfologia nos diferentes substratos. Quando a confluência 
celular foi atingida, foi introduzido um meio de diferenciação osteogénico e o cultivo continuou por 14 
dias. Finalmente, CF e um ensaio de imunocitoquímica de osteocalcina foram realizados de modo a 
avaliar como as diferentes topografias dos biomateriais influenciavam a diferenciação osteogénica. 
A primeira análise de CF confirmou que as células utilizadas eram CEM’s humanas. No quarto 
dia, os resultados de MTS mostraram que a proliferação foi similar em todos os substratos. A MEV e 
o ensaio de imunocitoquímica de vinculina mostraram que as CEM’s adotaram diferentes morfologias 
dependendo do biomaterial. Adicionalmente, CF mostrou uma perda de marcadores específicos das 
CEM’s em meio de expansão e 14 dias depois da introdução de meio osteogénico, as células cultivadas 
nos filmes planos e com micropartículas revelaram existência de osteocalcina e perda de marcadores. 
Concluindo, as novas topografias com micropartículas de PVDF permitiram um incremento na 
diferenciação de CEM’s. As células proliferaram satisfatoriamente e a morfologia adotada nos 
substratos sugere aderência às microesferas. Concluindo, estes suportes mostraram induzir perda de 
multipotencialidade das CEM’s cultivadas em meio de expansão, mesmo antes da confluência celular. 
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ABSTRACT 
Mesenchymal Stem Cells (MSCs) have attracted great interest in the scientific community in 
the past few years due to their differentiation potential towards cells belonging to the musculoskeletal 
lineages, such as adipocytes, osteoblasts, and chondrocytes. In this work, human MSCs were 
combined with poly(vinylidenefluoride) (PVDF), a biocompatible piezoelectric polymer, allowing their in 
vitro expansion and proliferation, with the main goal of obtaining an important number of cells with 
osteoblastic phenotype for tissue regeneration. 
With this purpose, α-phase PVDF films were subjected to PVDF electrospray with different 
deposition times, producing two substrates, with high and low concentration of β-phase PVDF 
microspheres. Microspheres only were also produced to create a 3D environment. Flat β-phase films 
were used as reference. Before cell seeding, the characteristic cell surface markers of MSCs (CD105, 
CD90 and CD73) were analyzed by flow cytometry (FC). Cells were cultured onto the biomaterials and 
viability was assessed after 4 days. In parallel, FC, Scanning Electron Microscopy (SEM) and 
immunocytochemistry of vinculin were performed in order to evaluate the maintenance of MSCs 
multipotentiality and their morphology on the different substrates. When the confluence was reached, 
osteogenic differentiation medium was introduced and the culture was continued for 14 days. Finally, 
FC and an osteocalcin immunocytochemistry were performed in order to evaluate if the different 
substrate morphologies influenced MSCs osteogenic differentiation.  
First FC analysis confirmed that cells were actually human mesenchymal stem cells. At the 
fourth day, MTS results showed similar proliferation in all the substrates. SEM and vinculin 
immunocytochemistry have shown that a different morphology was adopted by MSCs depending on 
the substrate. Also, FC indicated loss of specific MSCs markers in expansion medium. After 14 days 
of osteogenic medium introduction, cells cultured on flat films and films with microspheres revealed 
osteocalcin staining and again, loss of multipotentiality. 
Concluding, this new shaped PVDF microspheres substrates were able to enhance hMSC’s 
differentiation. Cells proliferated at high rate and their morphology in the substrates suggests that these 
cells are adhering onto microspheres. Moreover, these supports’ topography induces loss of 
multipotenciality in MSCs cultured in expansion medium, even before reaching confluence.
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1 INTRODUCTION 
Biomedical engineering has been defined as an extension of chemical engineering towards 
biomaterials [1]. Tissue Engineering (TE) is one of its main branches. Various disciplines, such as 
materials science, cell biology, reactor engineering, as well as clinical research contribute to tissue 
engineering. 
The development in the TE field – in which new tissues are created from cultured cells and 
biomaterials – has been driven by the shortage of donor tissue, that limits the number of people who 
receive life-saving organ and tissue transplantations [2]. Biomaterials serve both as a transplant vehicle 
for the cells of interest and as template guiding tissue regeneration. These are named scaffolds and 
may also be utilized to deliver specific biological factors which will induce new tissue formation from 
cells already present in the surrounding tissue [3].  
TE field relies extensively on the use of porous 3D scaffolds to provide the appropriate 
environment for the regeneration of tissues and organs. These scaffolds are seeded with cells and 
growth factors or subjected to biophysical stimuli in the form of a bioreactor – a device or system which 
applies different types of mechanical or chemical stimuli to cells (Figure 1.1) [4]. The extracellular 
matrix (ECM) secreted by the living cells will create a suitable environment, enhancing the native 
capacity of cells to integrate, proliferate and differentiate [5]. The addition of growth factors and other 
ECM components should also promote the intercellular communication and attachment of cells to the 
scaffold, inducing proliferation [6]. 
To fabricate these scaffolds, a variety of biomaterials, including synthetic polymers, ceramics 
and naturally derived proteins are being utilized. Also, biological materials such as collagen, 
proteoglycans, alginate-based substrates and chitosan have all been used in the production of scaffolds 
for tissue engineering [7]–[9]. They are biodegradable and so allow host cells to produce their own 
ECM over time and replace the degraded scaffold. Moreover, they are biologically active and promote 
excellent cell adhesion and growth. However, fabricating scaffolds from biological materials with 
homogeneous and reproducible structures presents a challenge. In addition, the scaffolds generally 
have poor mechanical properties, which limits their use [4].  
Therefore, in the past few years, synthetic polymers are being increasingly used for 
therapeutics and it is believed that many further developments in medicine will be achieved thanks to 
such materials [10]. 
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Figure 1.1 – Tissue engineering triad. Cells of interest, signals – provided chemically by growth factors or physically by a 
bioreactor – and the scaffold which acts as a template for tissue formation by allowing cells to migrate, adhere, and produce 
tissue [4]. 
 
1.1  ELECTROACTIVE POLYMERS AND “ACTIVE” TISSUE ENGINEERING 
Polymers have attractive properties compared to inorganic materials. They are lightweight, 
inexpensive, fracture tolerant and easily processed and manufactured. They can be configured into 
complex shapes and their properties can be tailored according to demand [11]. A variety of synthetic 
polymers such as poly(lactic acid) (PLA), poly(glycolic acid) (PGA), poly(lactic-co-glycolic acid) (PLGA), 
poly(ethylene glycol) (PEG) and polycaprolactone (PCL) have been widely used to produce 
biomaterials/scaffolds for tissue engineering [12]. 
With the rapid advances in materials used in science and technology, various materials with 
intelligence embedded at the molecular level are being developed at a fast pace. These smart materials 
can sense variations in the environment, process the information and respond accordingly; in other 
words, they can respond to external stimuli – such as electrical field, pH, a magnetic field, and light – 
by changing shape or size [13]. These smart polymers can collectively be called active polymers. 
Polymers that respond mechanically to electrical stimulation are called electroactive polymers 
(EAP) and are classified depending on the mechanism responsible for actuation. They are divided as 
electronic EAPs – which are driven by electric field or coulomb forces – or as ionic EAPs – which 
change shape by mobility or diffusion of ions and their conjugated substances [14]. Their 
electromechanical response, exhibiting large strain when subjected to electrical stimulation, makes 
them the human-made actuators that most closely imitate natural muscles. For this ability, EAP 
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materials have earned the name “artificial muscles” [11]. Their main characteristics are resumed in 
Table 1.1. 
 
Table 1.1 – Summary of the main characteristics of electronic and ionic EAPs. 
Electronic EAPs 
 Require high activation fields (>100 V.μm-1), which are close to the electric 
breakdown level of the material; 
 The applied electric field may induce a molecular conformation change as the 
dipoles are aligned with the field; 
 Since the actuation does not involve diffusion of charge species, they are able to 
respond quite fast (<10−3 s). 
 Induces relatively large actuation forces; 
 Can hold strain under DC activation. 
Ionic EAPs 
 Can perform a much more pronounced deformation of the material; 
 Require low driving voltages, nearly equal to 1–5 V; 
 They must be operated in a wet state or in solid electrolytes; 
 They have slow response characteristics when compared to electronic EAPs; 
 High currents require rare earth electrodes such as gold or platinum; 
 The majority aren’t able to hold strain under DC voltage. 
  
As polymers, EAP materials have a lot of attractive properties that are superior to other 
materials. EAP can be easily formed in various shapes and their properties can be engineered. They 
can be geometrically designed to bend, stretch or contract.  
Integrating such molecular EAP materials into nanoscale and mesoscale devices, although a 
great challenge, can lead to new applications in the EAP field. Hence, these polymers are among the 
most interesting classes of polymers used as smart materials in numerous applications, such as 
sensors, actuators, energy and as biomaterials in the biomedical field, among others [15]. 
Piezoelectric materials are the most suitable for biomedical applications since they have also 
the interesting ability to vary surface charge when a mechanical load is applied, without the need for 
an external power source or connection wires [16]. Thus, the use of intrinsically charged piezoelectric 
polymers as tissue culture substrates can provide means of exposing cells directly to local time-varying 
electrical stimuli and enhance their response. 
Fukada and Yasuda (1957) were the first to report bone piezoelectricity [17]. They have shown 
that the piezoelectric effect appears when the shearing force acts on the oriented collagen fibers so 
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that they slip past each other. Then, Basset (1968) [18] reviewed the biologic significance of 
piezoelectricity, reporting that DC current flow produces massive osteogenesis and bone formation. 
Also, it is known that electrical proprieties of bone are relevant not only for bone remodeling, but also 
as a stimulation for bone healing and repair [19], [20]. All of these studies proved that stressed bone 
exhibits electronegativity in areas of compression and that, upon fracture, the active metabolism and 
essentially the growing part of bone was also found to be negatively charged. This negative potential 
will produce current from the neighboring tissue [20]. 
A different approach was introduced by Fukada et al. (1975), where a piezoelectric material 
(electret) was implanted and tested. The results showed bone formation beneath the films and it was 
attributed to charges developed by deformation of the electret films [21], [22]. Additionally, it has been 
proved that a piezoelectric biological ceramic, hydroxyapatite and barium titanate was able to promote 
growth and repair of jawbones in dogs. Their chewing-promoted stress potential generated an electrical 
current that promoted osteogenesis [23]. Since then, many studies were performed and some of them 
proved that cell dynamic culturing and inherent piezoelectric materials enhanced proliferation and 
differentiation to osteogenic lineage, being more biomimetic than other used biomaterials, due to the 
electrical stimulation produced by mechanical stimulation with bioreactors, for instance. This concept 
can be called as “active” tissue engineering and has 
been successfully used in the past few years for bone 
formation, healing and regeneration (Figure 1.2) 
[24]. Basically, this approach completes the before 
mentioned tissue engineering triad by adding to the 
system physical stimulus provided by bioreactors, 
which attempt is to simulate in vivo physiological 
environment, as mentioned. 
  
Figure 1.2 – Strategies for the new “active” tissue 
engineering concept with bioreactors [24]. 
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1.2 POLY(VINYLIDENEFLUORIDE) AS A POLYMER OF CHOICE: PROPERTIES AND HANDLING 
From the short choice of piezoelectric polymers (including poly (L-lactic acid) (PLLA) and 
poly(hydroxybutyrate) (PHB)), poly(vinylidenefluoride) (PVDF) and its co-polymers are still the ones with 
the best electroactive performance, showing the largest piezo, pyro, and ferroelectricity responses [25]. 
The possibility of tailoring PVDF properties and microstructure, allows new and challenging applications 
in the biomedical area, not only in device applications but also induce targeted cell responses [26]. 
This semi-crystalline and biocompatible polymer shows a complex structure and can present five 
distinct crystalline phases (β-, α-, δ-, γ-, ε-) related to different chain conformations designed as all 
trans (TTT) planar zig-zag for the β-phase, TGTG’(trans-gauche–trans-gauche) for the α- and δ-phases 
and T3GT3G’ for γ- and ε-phases [15]. 
Many of the interesting properties of PVDF, in particular those related with its use as sensor 
or actuator, are related to the strong electrical dipole moment of the PVDF monomer unit 
((5 – 8) × 10−30 Cm) which is due to the electronegativity of fluorine atoms as compared to those of 
hydrogen and carbon atoms [27]. The polar β-, γ- and δ-phases have an overall dipolar contribution 
per unit cell, as the monomer units and therefore the dipolar moments are packed in a unique 
morphology (Figure 1.3-A). The β-phase has the strongest piezoelectric response found among 
polymers (highest dipolar moment per unit cell – 8 × 10−30 Cm), being the most electrically active 
phase, followed by the γ-phase [15]. 
Different strategies have been therefore developed to obtain the electroactive phases of PVDF, 
mainly focusing on the development of specific processing methods and the inclusion of specific fillers. 
The β-phase can be obtained by mechanical stretching of the α-phase; from melt under specific 
conditions such as high pressure, external electric field and ultra-fast cooling (Figure 1.3-B); from 
solvent casting; or by the addition of nucleating fillers such as BaTiO3, clay, hydrated ionic salt, 
poly(methyl methacrylate) (PMMA), TiO2 or nanoparticles such as ferrite, palladium or gold. Also, the 
development of PVDF copolymers such as poly(vinylidene fluoride-trifluoroethylene) (PVDF-TrFE) has 
allowed to obtain this material in the electroactive phase [15].  
Usually, PVDF and other commonly used piezoelectric polymers are mechanically stretched 
followed by corona poling in order to induce a net dipole in the material [28]. 
Another important issue is that due to the similarity of β- and γ-phase specific conformations, 
their characteristic Fourier Transformed Infrared Spectroscopy (FTIR) bands and X-ray diffraction (XRD) 
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peaks (which are typically used for phase identification) either coincide or are very close to each other, 
making difficult to distinguish among both phases [15]. For that, a careful interpretation of the results 
provided by FTIR, XRD and Differential scanning calorimetry (DSC) should be enough to identify the 
correct phase of PVDF. Therefore, the combination of different techniques is needed in order to 
correctly identify α-, β- and γ-phases, since there is superposition of the peaks on each of the different 
techniques [29]–[31]. 
 
Additionally, this polymer has the appropriate mechanical, thermal and chemical properties 
for biomedical applications [32], since it can be produced in the form of fibers, films or porous 
structures allowing the production of materials with a customized microstructure for these 
applications [33]–[35]. 
 
1.3 DESIGN AND DEVELOPMENT OF SCAFFOLDS/BIOMATERIALS FOR TISSUE ENGINEERING 
APPLICATIONS 
As mentioned above, in the last years, the potential of electroactive polymers has been 
recognized for biomedical applications. In this sense, these materials can be used as smart scaffolds 
to stimulate cell growth and compatibility, biosensors, mechanical sensors and actuators, among 
others [25]. Therefore, in tissue engineering, the polymeric scaffold material serves as a biomimetic 
template for cell adhesion, proliferation, differentiation and ECM formation and mineralization; thereby 
providing a favorable environment for rapid regeneration of tissue [36]. 
B 
A 
Figure 1.3 – A) Schematic representation of the chain conformation for the α, β and γ phases of PVDF [15]. B) Obtaining 
the β-phase conformation of PVDF. Schematic of the molecular shape change [14].  
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As a result, biocompatibility and biodegradability are the two main ideal properties required for 
these biomaterials [37]. They should not elicit any short- or long-term immune response. Similarly, 
polymers and their degradation products should not be toxic to cells or tissues or affect the normal 
physiological functions [38]. Implantation of inert biomaterials may lead the immune system to cause 
encapsulation of the implant in fibrogen and platelets as an attempt to remove the foreign material 
from the site of the tissue. This encapsulation can lead to further complications, since the thick layers 
of fibrous capsulation may prevent the implant from performing the desired functions [39]. 
So, the demand for an electroactive polymer to be used in TE that: (i) can be biocompatible, 
(ii) does not elicit unnecessary inflammatory response, (iii) does not demonstrate any adverse immune 
response or cytotoxicity, (iv) and that, similarly with all materials in contact with the human body, can 
be sterilizable to prevent infection, is an great challenge in the TE field. In addition, the mechanical 
properties of the polymeric scaffold must be compatible and should not collapse during surgical 
implantation or during the patient’s regular activities [36]. 
 
1.3.1 Interaction between cells and biomaterials 
Cells and materials interplay a central issue in tissue engineering, as the physicochemical 
properties of scaffold materials affects cell behavior. The compatibility and cell response are strongly 
influenced by the surface properties of the biomaterial, such as surface charge, chemical composition 
surface energy, morphology, hydrophobicity and roughness, which will have an effect on cells 
attachment, spreading, differentiation and maturation [40]. Accordingly, different cells may behave 
differently on materials, depending on their architecture: the cellular response is strongly influenced 
by the interconnectivity, pore size/curvature, microporosity and macroporosity [16]. Strong research 
efforts have been devoted to the tailoring of physicochemical properties of biomaterials: their chemical 
composition, wettability and topography, in order to induce appropriate cell responses [41]. Proving 
this concept, Huag et al. (2009) showed that two different cell lines cultured in vitro, osteoblast 
hFOB1.19 and fibroblast L929, exhibited different responses on different membranes: the hFOB1.19 
cells showed an intensified cell proliferation with an increase of surface roughness, whereas the L929 
cells demonstrated the opposite, preferring to attach and grow on a flat surface [42].  
Additionally, an interconnected pore structure and high porosity will ensure cellular 
penetration, adequate diffusion of nutrients to cells within the construct and allows diffusion of waste 
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products out of the scaffold [4]. A successful scaffold should balance mechanical function with 
biofactor delivery, making a transition over time in which the regenerated tissue assumes function as 
the scaffold degrades. This balance often forces a choice between a denser scaffold providing better 
function and a more porous scaffold providing better biofactor delivery [43]. The role of porosity and 
pore size in 3D scaffolds was recently reviewed in [44]. 
Scaffolds can be prepared by different types of fabrication techniques. Since the biopolymer 
characteristics are determined by the chosen fabrication technique, it is important to be able to control 
it. The choice must always be done regarding the bulk and surface properties of the polymer and the 
proposed function of the scaffold. The main techniques for scaffolds fabrication include for example 
solvent casting, gas foaming, self-assembly, electrospinning, phase separation, fiber mesh, fiber 
bonding, melt molding, membrane lamination and freeze drying [45]. 
 
1.3.2 Electrospraying 
It is possible to notice, by analyzing aforementioned recent tissue engineering studies with 
PVDF and so many others with different polymers (recently reviewed in [46], [47]), that electrospun 
polymer nanofibers are proper materials for cell culture. Their fine structures resemble natural 
extracellular matrices and can efficiently interact with cell surfaces and promote cell proliferation. 
However, the fabrication of 3D scaffolds from electrospun nanofibers is still very difficult due to the 
fibers continuous entangled form, limiting their application to 2D or single tube-like scaffolds [48]. 
To address this problem, the production of polymeric microspheres by electrospraying may be 
the most suitable method, since it has the potential to overcome limitations of the traditional 
emulsion-based techniques and can, additionally, provide reproducible nano- and microspheres [49]. 
Moreover, this technique has the potential to generate narrow size distributions of particles with low 
agglomeration or coagulation and convenient encapsulation with high yields [50].  
In electrospinning, the viscosity of the polymer solution affects the morphology of the final 
product [51]. By decreasing viscosity, the polymer solution jet is gradually thinned and the diameter of 
the fiber becomes nonuniform, which results in a beaded fiber – an undesired product in 
electrospinning. In electrospraying, the viscosity is further decreased, so the polymer jet breaks up into 
tiny droplets and microspheres are obtained [52]. Simultaneously, the ambient humidity and volatility 
of the solvent affect the surface morphology of electrospun products. The difference between the 
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electrospinning and electrospraying techniques lies in the chain entanglement density of the polymer 
solution [53]. For this reason, the determination of a critical polymer concentration is of utmost 
importance, because it can dictate the behavior of electrospraying/electrospinning. 
In the electrospraying process (Figure 1.4-A), a polymer solution is loaded into a syringe and 
infused at a constant rate using a syringe pump through a small but highly charged capillary. A collector 
is placed at a 7 to 30 cm distance from the capillary and the applied voltage is typically up to ± 30 kV. 
When the power supply is turned on, at the tip of the steel capillary two major electrostatic forces 
(electrostatic repulsion of like charges and Coulombic force of the external electric field) force the 
hemispherical surface of the droplet to distort into a conical shape known as the Taylor cone (Figure 
1.4-B). Once droplets detach from the Taylor Cone, which is when the electrostatic forces counteract 
the surface tension, the solvent evaporates, generating dense and solid particles that end attached to 
the collector [49]. 
 
 
Figure 1.4 – A) Schematic of the typical electrospraying setup [49]. B) The Taylor Cone, from which a jet of charged 
particles emanates above a threshold voltage [54]. 
 
During the electrospray process, there are various parameters that need to be optimized 
according to the desired final product. These include: voltage, distance to collector, needle gauge, flow 
rate, polymer, drug, solvent, surfactant, protein/polymer ratio and organic/aqueous ratio [49]. 
Therefore, before proceeding to this technique, there must be an identification of key parameters 
responsible for particle size, distribution and morphology as a prelude to any further investigation. 
 
A B 
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1.4 MESENCHYMAL STEM CELLS 
Since the first non-hematopoietic adult Mesenchymal Stem Cells, MSC’s, description by 
Friedstein et al. (1966) [55], many studies have been carried out through the next years. They 
established that these cells derive from stromal compartment of bone marrow (BM) and that seeding 
of BM cell suspensions at clonal density results in establishment of colony-forming units [56]. The 
name “osteogenic stem cell” or “BM stem cell” came when Owen and Friedenstein carried out in vivo 
transplantation and recognized that bone, cartilage, adipose and fibrous tissue could be experimentally 
generated starting from a single BM stromal cell [57]. 
In this line of thought, MSC’s are nowadays defined as multipotent cells that adhere to plastic, have a 
fibroblast-like morphology, express a specific set of surface antigens and have great interest in the 
scientific community due to their differentiation potential towards cells belonging to the musculoskeletal 
lineages, such as adipocytes, osteocytes and chondrocytes [58] (Figure 1.5). 
 
 
 
Even though MSC are usually isolated from BM aspirate of the superior iliac crest of the pelvis 
in humans, MSC’s have also been isolated from a number of other tissues including periosteum, 
Figure 1.5 – The progeny of a MSC can be induced into one of the several mesenchymal lineage pathways [62]. 
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trabecular bone, adipose tissue (AT), synovium, skeletal muscle, scalp tissue, decidous teeth, placenta 
and umbilical cord blood (UCB) [59], being the most common ones from BM, UCB and AT; a 
comparative analysis was carried out by Kern et al. (2006) [60]. 
Recently, a new insight was attributed to MSC’s and they were named as in vivo “drugstores”. 
Given that MSC’s were revealed to be perivascular in vivo [61], Caplan and Correa (2011) proposed 
that MSC’s leave their perivascular location during a local injury and secrete bioactive molecules that 
will help to regenerate tissue by creating a suitable microenvironment, thus regulating the local immune 
response [62]. 
So, these cells have an enormous potential for clinical use mainly due to: i) their ability to self-
renew to a certain extent and differentiate; ii) displaying a variety of important cell functions in the 
organism, including migration and transport functions to damage sites, helping on their renewal; iii) 
avoiding allogenic rejection, being therefore, non-immunogenic [63]. 
It’s important, however, to ensure that hMSC’s (human MSC’s) do not lose their potency during 
sub-culturing passages. This is one of the major challenges, since cells were found to decrease 
telomerase activity during in vitro expansion, which will result in an increase of the probability of 
malignant transformation and a decline in their multipotency [64]. Thus, culturing early hMSC’s will be 
more reliable for in vitro culture purposes. Also, it has been shown that hMSC’s obtained from young 
donors can undergo ±40 population doublings in vitro, but the hMSC’s obtained from older donors 
have a more compromised proliferative potential (±24 population doublings) [65]. Despite the fact that 
a decrease in osteoblastic function was not noticed, it is still more reliable to culture cells with low 
population doublings to apply in in vitro proof-of-concepts. 
 
1.4.1 Minimal criteria for defining mesenchymal stem cells 
As MSC’s lack a specific marker that can be used to isolate and characterize them, the 
International Society for Cellular Therapy (ISCT) proposed a series of standards to define MSC’s [58]. 
One of the standards is that cells must have adherence to plastic when cultured in standard conditions. 
Moreover, they must have a specific surface antigen expression, specifically ≥ 95% of the MSC’s must 
express CD105, CD73 and CD90, and lack expression of CD45, CD34, CD14 or CD11b, CD19 or 
CD79α and HLA (human leukocyte antigen) class II (≤ 2% positive). These have been widely used for 
identification of MSC’s [66]–[70]. Finally, under standard differentiating conditions in vitro, they should 
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be able to differentiate onto adipocytes, osteoblasts and chondrocytes, showing multipotent 
differentiation potential. 
There are various methods for MSC’s identification, verification and characterization being the 
most used, flow cytometry. Immunofluorescence/Immunocytochemistry, western blot, protein arrays 
and real-time RT-PCR can also be employed and are the most common methods for identifying MSC’s 
identity [71]. 
The markers that the ISCT proposed are the ones that enable researchers to distinguish MSC’s 
from other cells present in the bone marrow (BM). Therefore, the positive markers are the surface 
antigens that hematopoietic stem cells (HSC’s) do not express; and the negative markers are the 
antigens expressed by HSC’s. Below, each one of the antigens as well as where they are expressed 
and which type of cells express them will be shortly explained. 
As hMSC’s process the HLA’s corresponding to the major histocompatibility complex class I 
protein (MHC I) instead of MHC class II they have shown to have non-immunogenic surface antigens 
[72]. The HLA-DR, a class II HLA is only expressed by the MSC’s when stimulated, e.g. by interferon 
gamma (IFN-γ) [73]. HLA’s that correspond to the MHC class II are only present on antigen-presenting 
cells (APC’s), such as B-cells, monocytes, macrophages and dendritic cells [74]. 
CD45 is an antigen encoded by the PTPRC gene, also known as protein tyrosine phosphatase, 
receptor type C. It is present on all nucleated hematopoietic cells and has an essential role in normal 
T and B-cell development and antigen receptor signaling [75]. 
CD14 acts as a co-receptor for mediating the innate immune response to bacterial 
lipopolysaccharide and it is manly present in monocytes and macrophages, the most likely 
hematopoietic cells to be found in a MSC culture [76]. 
The B-lymphocyte antigen CD19 is a surface marker that, as the name indicates, is expressed 
early during pre-B-cell differentiation and its expression remains until final differentiation into plasma 
cells. It is expressed by all B-cells and follicular dendritic cells [77]. On mature B-cells, CD19 is a 
coreceptor molecule to the B-cell receptor (BCR), which is involved in signal transduction, processing 
of antigens and subsequent presentation of peptides to helper T-cells [78]. It may also adhere to MSC’s 
in culture. 
Hematopoietic progenitor cell antigen CD34 is a member of a family of single-pass 
transmembrane proteins and may play a role in attachment of stem cells to the BM extracellular matrix 
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or stromal cells, although the function of CD34 and its family members has not yet been fully 
determined. This antigen marks primitive hematopoietic progenitors and endothelial cells [79]. There 
is some controversy in having CD34 as a negative marker for characterization of MSC’s; several groups 
have shown that MSC’s express CD34, as reviewed elsewhere [72] and that lacking CD34 expression 
is likely a consequence of MSC’s culturing instead of the real nature of these cells [80]. 
The ones that are certain to be positive biomarkers for MSC’s are CD105, CD90 and CD73. 
Endoglin or CD105 is a membrane protein that is part of the transforming growth factor beta 
(TFG-β) receptor complex. This molecule, expressed by MSC’s and other cells within the BM, 
modulates the TFG-β signaling by interacting with activin and bone morphogenic protein in the 
presence of their respective ligand binding receptor [81]. Although it has not been clarified yet, it is 
thought that this molecule may play an functional role in stem cell differentiation, since it has been 
reported that members of the TFG-β family control MSC’s differentiation [82]. A decrease in the 
expression of this marker has been related to multi-lineage differentiation of MSC’s [83], [84]. 
CD90 or Thy-1 is conserved glycophosphatidylinositol (GPI) cell surface protein. It is expressed 
on thymocytes, peripheral T cells, fibroblasts, epithelial cells, neurons, MSC’s and HSC’s [85] and has 
a role in cell-cell and cell-matrix interactions as well as cell motility [86]. This molecule was considered 
to be a transient marker for early osteogenic differentiation of MSC’s, since it has been proved its 
expression decreased while there was an increase of other osteogenic markers [83], [87]. 
Finally, CD73 also known as ecto-5'-nucleotidase is a GPI-linked membrane glycoprotein which 
catalyzes the conversion of extracellular nucleoside monophosphates into bioactive membrane 
permeable nucleosides, e.g. adenosine monophosphate (AMP) to adenosine [88]. Its loss has also 
been related to differentiation of MSC’s into different lineages, specially onto chondrocytes and 
osteoblasts [83], [84]. 
A summary of the above mentioned markers and their roles is presented in Table 1.2. 
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Table 1.2 – Negative and Positive markers as proposed by the ISCT. Adapted from [71]. 
Negative Marker HLA Class II CD45 CD14 CD19 CD34 
Used to exclude 
APC’s and 
lymphocytes 
Leukocytes 
Monocytes and 
macrophages 
B-cells 
Primitive 
hematopoietic cells 
and endothelial cells 
Positive Marker CD105 CD90 CD73 
Biological Role 
Catalyzes the production of 
extracellular adenosine from AMP 
Wound repair; cell-cell and 
cell-matrix interactions 
Vascular homeostasis; modulates 
TGF-β functions 
 
1.4.2 Osteogenic differentiation 
The osseous tissue has a unique capacity to heal and remodel without scarring. Bone 
formation or skeletal development and its regulation and homeostasis require a series of coordinated 
functions performed by multiple cell types and tissues. Its formation and renewal, called remodeling, 
is of utmost importance for the human body, since it provides skeletal support, serves as a reservoir 
for calcium and phosphate, maintaining the blood calcium levels, and provides a suitable niche for 
hematopoiesis [59]. 
Bone resorption is carried out by osteoclasts, which are derived from HSC’s. Mature 
osteoblasts, derived from MSC’s as before stated, can synthesize bone matrix that becomes 
mineralized, rebuilding the resorbed bone. These cells can further differentiate onto osteocytes (Figure 
1.6) [89]. 
Although this is a natural mechanism, it is essential to understand bone formation, remodeling 
and its regulation in order to come up with additional bone-building treatments, since there are several 
conditions, both congenital and acquired, where bone replacement and treatment of bone defects are 
needed. Additionally, since the population aging continues to grow, these problems are expected to 
increase. The most used surgical procedure is autologous grafting, which is the “gold standard” in 
immunocompatibility. However, there are several disadvantages in this procedure: e.g. limited amount 
of tissue that can be harvested, requirement of a secondary surgery, recurrent pain, etc. [90]. Also, 
allografts or xenografts are optional treatments, although they bring other disadvantages including the 
possibility of graft rejection, risk of infections and transmission of donor pathogens. 
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To overcome these problems, tissue engineering and osteogenic differentiation performed on 
biomaterials is emerging as an appropriate alternative to grafts and to regenerate bone from MSC’s of 
the host body.  
As before mentioned (section 1.1), bone is known to have inherent piezoelectricity and 
therefore to react to mechanical and electrical stimuli. This reaction is responsible for maintaining bone 
heath and integrity, since it has been proved that biophysical signals, including fluid shear stress, 
substrate strain, substrate topography and electromagnetic fields are transduced by MSC’s and act on 
direct regulation of osteogenic differentiation, and, therefore to higher bone density and greater fracture 
resistance [91]. Specifically, osteocytes are known as mechano-sensing cells that act as transducers, 
converting the whole mechanical stimuli to chemical and biological signals for MSC recruitment, 
proliferation and differentiation. 
 
 
Beyond biophysical signs, osteoblast differentiation from MSC’s is also mediated via several 
signaling molecules such as morphogens, hormones, growth factors, cytokines, matrix proteins and 
transcription factors [59]. Runt-mediated transcription factor 2 (Runx2) and osterix, along with Wnt 
Figure 1.6 – The four types of cells found within the bone matrix. Osteogenic cells are undifferentiated and can develop to 
osteoblasts. Osteoblasts intervene in bone formation and when they get trapped within the self-calcified matrix, they become 
osteocytes, which have a different structure and function. They maintain the matrix mineral concentration via secretion of 
enzymes. Osteoclasts are very different in appearance from the other cells and develop from monocytes and macrophages. 
The latter resorb old bone [149].  
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signaling drive stem cells to differentiate onto pre-osteoblasts [92]. Alkaline phosphatase (ALP) 
expression starts to be noticed in committed pre-osteoblasts and so can be considered an early marker 
of osteogenic differentiation. Then, once they evolve to mature osteoblasts, a phenotypic change can 
be noticed: larger nucleus, enlarged Golgi, and extended endoplasmic reticulum. Additionally, this 
supports the idea of production of ECM and secretion of bone matrix proteins, such as collagen type I, 
which is dependent also on compressive and shear stresses [93]. When cell becomes finally 
differentiated into an osteocyte, they occupy a specific place in bone lacunae and also undergo 
phenotypic changes as the appearance of extensive filopodia, which allows connection with adjacent 
cells (Figure 1.6). Osteocytes can also regulate osteoblast and osteoclast activity and contribute to 
mineral metabolism [91]. When in this mineralization state phase, cells increase ALP activity and 
express late markers of differentiation such as osteocalcin and osteopontin and bone sialoprotein [94].  
 
1.5 STATE-OF-ART 
Now, it is known that many body tissues – such as bone, nervous and also muscle – react to 
mechanical and electrical stimuli. So, the use of electroactive films, membranes or scaffolds shows a 
novel and potentially interesting approach for tissue engineering applications, making piezoelectric 
polymers a physical template for cell adhesion and to carry electrical signals, thus improving tissue 
regeneration. In this line of thought, piezoelectric materials can provide a unique approach to mimic 
natural cell environment, allowing for electric or mechanic cues similar to the ones present in human 
body and therefore improving differentiation of hMSC’s, to the osteogenic lineage, for instance [95].  
 
1.5.1 Osteogenic differentiation on microspheres scaffolds 
Recently, many studies have found applicability for numerous materials in microspheres 
scaffolds. They can be fabricated by several techniques including emulsification, solvent evaporation 
techniques, dissolution precipitation techniques and, recently, with electrospray. Also, they have 
several advantages comparing to conventional scaffolds and these will be reviewed in this section.  
These are versatile, given that they can be engineered to modify composition, particle size, 
size distribution and morphology. Even porous microspheres have already been produced to be used 
as cell delivery carriers [96]. Also, microspheres have the ability to hold and release bioactive molecules 
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in a more controllable way that other materials, and as a result they are being widely used as a growth 
factor delivery system [97]. Their morphology allow them to respond to various stimulus from the 
surrounding environment, and can consequently perform triggered release by responding to external 
stimulation [98]. 
Furthermore, microspheres made of biocompatible polymers containing self-adhesive peptide 
sequences which can serve as a cell delivery vehicle either by inside cell encapsulation or attachment 
of the cells on their surface. Osteoblasts, as anchorage-dependent cells, can utilize this microspheres 
as anchorage site, creating a suitable niche for new bone formation [98]. 
Additionally, there are two different ways in which these microspheres can be delivered to the 
target site: by sintering microspheres in a mould and then transfer it to the target site or by suspending 
the particles in an injectable delivery medium (suspensions and colloidal gels), and then inject it to the 
target site. The latter method is advantageous because is minimally invasive and there is no need of 
surgery for insertion of the implant [99].  
Among the large set of biomaterials employed on the manufacture of osteoinductive 
microspheres, here is a small review of studies that have been done in this area. So, microparticles or 
microspheres made of ceramics [100], calcium phosphate ceramics (CPCs) [101], [102], hybrid 
organic/inorganic compounds [103], [104], collagen [105], gelatin [106], alginate [107], chitosan 
[108], hydroxyapatite [109] and polymers, including PLG [110] and PLGA [111], [112] were reported 
as supports for cell studies of expansion and osteoblastic differentiation. Vascular endothelial growth 
factor A (VEGFA) loaded microspheres were reported to enhance osteogenic differentiation [113], as 
well as 17-b estradiol (E2) [111] and bone morphogenetic protein 2 (BMP2) loaded microspheres 
[106]; also, anti-BMP2 monoclonal antibodies encapsulation [107], dicalcium phosphate (CaHPO4) 
and calcium carbonate (CaCO3) composed microspheres [101], [104] have shown to help on this same 
differentiation pathway. 
Polymer microspheres have been extensively fabricated for TE applications primarily because 
of their easy processing and versatility. Although natural polymers offer inherent cues for directing stem 
cell fate, their biological activity can be lost during processing and the body can react with an induced 
immune response. Therefore, and also for their reasonable costs and strong control over proprieties, 
synthetic polymers advanced as one of the most suitable materials for microspheres elaboration [98]. 
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1.5.2 Osteogenic differentiation on poly(vinylidenefluoride)-based biomaterials 
Some studies involving PVDF and other piezoelectric polymers have been reported regarding 
cell biocompatibility. Previous studies investigated the biocompatibility of PVDF films and demonstrated 
PVDF as a very promising material for biomedical applications [25]. Also, it is easily manipulated: 
studies have been done with fibers [114] and membrane bends [115] for bone tissue engineering 
applications. Thus, and also given its piezoelectric proprieties, PVDF has been used as a support for 
cell culturing and osteogenic differentiation, especially in the past few years.  
In Table 1.3 is represented a review of the already accomplished studies of bone formation 
and osteogenic differentiation employing PVDF as biomaterial and their obtained results. Two of them 
have their ALP activity results below demonstrated (Figure 1.7). 
 
 
 Ribeiro et al. (2015) [116] used stem cells isolated from adipose tissue and performed the 
experiments at passages 2-4. After 7 days of static culture, part of the cell-cultured samples was 
transferred to a bioreactor system in order to perform the dynamic cultures. In the latter, the culture 
plate was placed in a vertical vibration module at a frequency of 1 Hz. The results clearly showed a 
higher osteogenic differentiation on “poled –” PVDF samples under dynamic conditions (Figure 1.7-A). 
Given this, it can be concluded that osteogenic medium and piezoelectric cell stimulation increased 
this effect, i.e. the combination of biochemical and electromechanical stimulus is the one that has 
shown better results, proving the theoretical concepts reviewed in this chapter. Also, they were able to 
Figure 1.7 – Relative amounts of ALP activity of stem cells cultured on β-PVDF samples in two different studies. A) [116]; 
B) [117]. 
B A 
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prove that fibronectin is a “sticky” protein, since that no significant differences were found between 
adsorbed films and crosslinked films with fibronectin. 
Also, Rodrigues et al. (2008) [117] isolated goat marrow stromal cells (GMC’s) from the iliac 
crests of adult bone and the experiments were done at passage 3 with osteogenic medium. Two days 
after static culture, part of the cell-cultured samples were transferred to a lab rotator. They have shown 
that these cells proliferated fast regardless of the sample. However, in dynamic conditions cells cultures 
on PVDF presented high proliferation rate when compared to TCPS, which proves the potential of 
piezoelectricity on stem cells proliferation. Also, it’s clear to see a huge increase on ALP activity when 
comparing static and dynamic conditions on the materials, which lead to the conclusion that 
mechanical stimulation really predisposed these cells to undergo osteogenic phenotype, which was 
then corroborated by the presence of calcium phosphates. 
These studies, along with the ones present in Table 1.3, can prove all of the concepts revised 
in this chapter, specifically of piezoelectricity and electromechanical stimulation. Now it’s possible to 
confirm that polarized materials have an influence on attachment and proliferation of cells. Most of all, 
these materials, like PVDF, are able to provide a similar environment to the one that exists in natural 
bone even under static conditions, enhancing, therefore, osteogenic differentiation. However, under 
dynamic conditions, these effects seem enhanced, mainly because these conditions mimic not only 
the electrical but also the mechanic stimulated environments existing in the body, and particularly, in 
bone, improving osteogenic differentiation and making this a suitable material to be explored in new 
bone regeneration strategies. 
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Table 1.3 – Review of studies that have been done with PVDF as a suitable material for bone regeneration or osteogenic differentiation and their specific results. 
PVDF morphology, phase 
and fillers 
Seeded Cells / 
Implant site 
“Dynamic culture” 
equipment 
Results Ref. 
 Non-poled and poled β-PVDF 
monomorph films and bimorph 
films 
Rabbit’s femur 
diaphysis 
- 
The osteogenesis is only induced in piezoelectric films and it’s greater in the bimorph 
films (which consists in sticking two of the monomorph films) 
[118] 
Non-poled β-PVDF and poled 
β-PVDF films 
Rat’s tibia and 
femur periosteum 
- 
More bone formation and periosteal reaction occurred in association with the 
piezoelectric β-PVDF implants 
[119] 
Electrospun β-PVDF (with 
different electrospinning 
voltages) 
Mesenchymal 
Stem Cells 
- 
The PVDF fibers supported and promoted osteogenic differentiation. The highest 
voltage used (25kV) encouraged cell adhesion and, therefore, enhanced differentiation 
[114] 
Non-poled and “poled +” 
β-PVDF films with and without 
titanium layer 
MC3T3-E1 
Bioreactor  
1 Hz 
“Poled +” PVDF films promoted higher osteoblast adhesion and proliferation. 
Dynamic culture improved even more these effects 
[16] 
γ-PVDF/MT-4;  
α-PVDF/NaY-32 
MSC’s 
differentiated to 
osteoblasts 
- 
Zeolite and clay composites are biocompatible, increased cell culture 
proliferation and did not show significant in vivo pro-inflammatory effect, shown by 
controlled vascularization at the implanted site (dorsal skinfold) 
[25] 
β-PVDF membranes 
Goat marrow cells 
(GMCs) 
Lab Rotator 
This material improved GMC’s adherence and proliferation and enhanced osteogenic 
differentiation both in static and dynamic culture conditions (Figure 1.7-B) 
[117] 
Non-poled, “poled +” and 
“poled –” β-PVDF and α-PVDF 
films 
MC3T3-E1 - 
Samples with a surface density of electrical charges show higher cell density and 
viability when compared to the non-poled β-PVDF films 
[26] 
PVDF with printed silver 
electrodes on both surfaces and 
covered with PMMA 
MC3T3-E1 
AC: 5V at 1 & 3 Hz 
15 min each. Once 
every 24 h 
Cells cultured in the actuator showed increase cell viability and gene expression of 
osteoblasts. The same conditions were applied in vivo and total bone area and new 
bone area was higher when comparing to static controls [120] 
[121] 
Non-poled, “poled +” and 
“poled –” β-PVDF and α-PVDF 
films 
Human Adipose 
Stem Cells 
- 
“Poled –” β-PVDF films exhibit highest total adhesion area and highest number of focal 
adhesions. Charged films exhibit a larger level of osteogenic differentiation 
[122] 
Non-poled and “poled –” 
β-PVDF films 
Human Adipose 
Stem Cells 
Bioreactor  
1 Hz 
The highest amount of osteogenic differentiation was obtained when culturing cells on 
“poled –” β-PVDF films, with osteogenic medium and under dynamic conditions 
(Figure 1.7-A) 
[116] 
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1.6 STRUCTURE OF THE THESIS 
Given all of the above explained topics, in this work, PVDF microspheres will be produced as 
a support by a novel method, electrospray, in order to evaluate the biological response of hMSC’s for 
tissue engineering applications. Three different and new biomaterials will be generated, two of them 
with an irregular “2D” topography of microspheres: electrospray deposition will be done with different 
lengths of time, producing two concentrations of microspheres adsorbed on films. The other will be 
produced as a new 3D microspheres cell-involving system.  
Briefly, chapter 2 will resume the main goals of this work. In chapter 3, the required materials 
and methods for the substrates production and characterization together with the required procedures 
for the isolation, expansion and differentiation of hMSC’s will be described in detail. Next, in chapter 
4, the results of the materials characterization will be presented and discussed, along with the results 
for cell response when seeded on different substrates and under different culture conditions. Finally, 
the last chapter will sum up this work, bringing the major conclusions and some final remarks about 
which one of the supports suits best for tissue engineering applications and for culture and 
differentiation of hMSC’s in specific cell lines; future perspectives will also be discussed. 
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2 OBJECTIVES 
The main goal of this thesis is to produce piezoelectric supports to evaluate the biological 
response of hMSC’s under static conditions for tissue engineering applications. 
During the development of the work, the main objectives are to: 
 Produce and characterize piezoelectric substrates for tissue engineering: β-phase 
PVDF polymeric microspheres and films with microspheres adsorbed in the same 
conformational phase; 
 Study the influence of processing conditions on phase content and crystallinity of the 
PVDF samples by FTIR and DSC, respectively; 
 Isolate and expand hMSC’s in cell culture conditions; 
 Study the influence of these biomaterials in cell response: cell viability, cell morphology 
and existence of focal adhesions. 
 Study the influence of this biomaterial on osteoblastic differentiation by flow cytometry 
and by an osteocalcin immunocytochemistry assay.  
 Evaluate the relevance/effect of the different biomaterials on hMSC’s differentiation. 
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3 MATERIALS & METHODS 
3.1 PROCESSING OF POLY(VINYLIDENEFLUORIDE) MICROSPHERES 
PVDF microspheres were obtained from electrospray method. For that, PVDF (Solef 1010, 
Solvay) was dissolved in N,N-dimethylformamide (DMF, Merk) with a concentration of 7% (w/w) in a 
magnetic stirrer with temperature control, at 60 ºC. It has been shown by Correia et al. (2014) that 
this PVDF concentration favors the formation of microspheres by electrospray method [24]. 
The polymer solution was then placed in a plastic syringe (10 mL) fitted with a steel needle 
with inner diameter of 0.25 mm. A syringe pump (NE-1000, Syringepump) fed the polymer solution 
into the tip at a rate of 2 mL.h-1. A foil was used as a collector. The distance between the tip of the 
needle and the collector was 20 cm, the needle being in horizontal position and the collector in vertical 
position, as shown in Figure 3.1. The experiment was conducted by applying a voltage of 20 kV with a 
high-voltage power supply (Glassman FC Series 120 W) and the electrodeposition time was about 
60 min. 
To recover the microspheres from the foil, ethanol was used. After evaporation, a powder of 
microspheres was obtained. These microspheres were then subjected to vacuum in a heated vacuum 
desiccator (“Vacuo-Temp”, Selecta) at 40 °C and 10-2 mmHg for 24 h, in order to remove residual 
solvent in the samples.  
 
 
 
Figure 3.1 – Representation of the electrospray equipment installation utilized in this work. 
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3.2 PROCESSING OF POLY(VINYLIDENEFLUORIDE) MICROSPHERES FILMS 
Films with adsorbed microspheres were also produced. For that, an α-phase PVDF film 
(Measurement Specialities) was subjected to electrospray, being the conditions equal to the ones used 
for microspheres processing. Two different concentrations of microspheres in the film were obtained: 
low concentration (15 min of microspheres deposition) and high concentration (45 min of 
microspheres deposition). “Poled –” β-phase flat PVDF films (Measurement Specialities) were used as 
control. 
The films were cut in 8 mm diameter circles and placed on 48-well non-treated tissue culture 
polystyrene plates (TCPS) (VRW). 
 
3.3 MATERIALS STERILIZATION 
For sterilization purposes, the films were subjected to ultra violet (UV) light overnight and then 
washed 3 times for 10 min with Dulbecco's Phosphate-Buffered Saline (DPBS) (ThermoFisher). The 
microspheres were washed 2 times with 100% ethanol and 5 times with DPBS for 10 minutes each. 
Then, these were also subjected to UV light overnight. 
 
3.4 FIBRONECTIN ADSORPTION 
FN from human plasma (Sigma-Aldrich) was adsorbed onto the PVDF samples. The 
biomaterials were immersed in a FN solution of 20 μg.mL-1 for 1 h under constant shaking. After protein 
adsorption, the samples were rinsed in saline solution to eliminate the non-adsorbed protein. 
 
3.5 CHARACTERIZATION OF POLY(VINYLIDENEFLUORIDE) SAMPLES 
3.5.1 Field Emission Scanning Electron Microscopy 
Electron microscopes use a beam of highly energetic electrons to probe objects on a very fine 
scale. Field emission (FE) is the emission of electrons from the surface of a conductor caused by a 
strong electric field. In this technique, a "cold" source is employed and a tungsten needle works as a 
cathode. The microscope is classified as a high vacuum instrument, allowing the electron movement 
along the column without scattering and helping to prevent discharges inside the gun zone. As the FE 
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source reasonably combines with scanning electron microscopes (SEM’s) and because the electron 
beam produced by the FE source is about 1000 times smaller than that in a standard microscope with 
a thermal electron gun, the quality of the images will be noticeably improved [123]. 
Therefore, the FE scanning electron microscopy (FESEM) seemed to be the right tool to ensure 
high-resolution surface imaging of the micrometer PVDF spheres and to analyze PVDF’s films surface. 
Thus, electrosprayed samples were coated with a platinum layer using a sputter coating (EM 
MED020, Leica) and their morphology was observed by FESEM (FESEM, Model Ultra 55, Zeiss), with 
an accelerating voltage of 3 kV. Then, microspheres average diameter was measured with Image J to 
approximately 550 microspheres using the FESEM images. 
 
3.5.2 Fourier Transform Infrared Spectroscopy 
The influence of the processing conditions on the crystalline phase and the polymer phase 
content of the PVDF samples were analyzed by FTIR. This technique has already shown to be useful 
in previous studies to identify and quantify the different crystalline phases of PVDF [15], [30], [124], 
[125]. 
FTIR was performed at room temperature in a ThermoNicoletNexus apparatus in Attenuated 
Total Reflectance (ATR). The spectra was obtained from 4000 to 400 cm-1, using 128 scans at a 
resolution of 8 cm-1. 
There are characteristic bands of each crystalline phase of PVDF, being the characteristic 
absorption bands for α- and β-phase at 766 and 840 cm-1, respectively (these will be reviewed further 
on section 4.2) [15]. Since the achievement of the electroactive β-phase of this polymer was of utmost 
importance in this work, as explained earlier, the relative fraction of the β-phase in these samples was 
determined using eqn(1) [126].  
 
𝐹(𝛽) =  
𝐴𝛽
(𝐾𝛽 𝐾𝛼⁄ )𝐴𝛼 + 𝐴𝛽
 (1) 
 
where 𝐹(𝛽) represents the β-phase content and 𝐴𝛼 and 𝐴𝛽 the absorbance at 766 and 840 cm-1, 
respectively. Gregorio and Cestari (1994) have also calculated the absorption coefficients, 𝐾𝛼 and 𝐾𝛽, 
at the respective wavenumber 766 and 840 cm-1, which are 6.1 × 104 and 7.7 × 104 cm2.mol-1, 
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respectively. It is assumed that FTIR absorption follows the Lambert-Beer law and that the samples are 
only composed of α- and β-PVDF [126]. 
 
3.5.3 Differential Scanning Calorimetry 
In order to determine possible modifications in crystal structure and melting behavior, a DSC 
measurements were performed in the PVDF samples. This thermoanalytical technique measures the 
difference in amount of energy (or heat flow) required to maintain the sample and a predefined 
reference at the same temperature [127]. 
These measurements were performed in a PerkinElmer DSC 8000 apparatus using a heating 
rate of 20 ºC.min-1 under nitrogen purge. At first, it was necessary to calibrate the equipment with a 
predefined reference. The samples for the DSC studies were weighed and pieces of approximately 
3.5 mg were placed into 30 μL aluminum pans. 
The process started at a minimum temperature of -80 °C and the sample was heated until it 
reached 200 °C at a heating rate of 20 °C.min-1. 
Ultimately, the degree of crystallinity (∆𝑋𝑐) of PVDF microspheres was calculated by 
measuring the melting enthalpy. Considering that the melting enthalpies for 100% crystalline samples 
of α- and β-phase PVDF are 93.07 J.g-1 and 103.4 J.g-1, respectively [124], the degree of crystallinity 
was determined using eqn(2): 
 
∆𝑋𝑐 =  
∆𝐻
𝑥∆𝐻𝛼 + 𝑦∆𝐻𝛽
 (2) 
 
where ∆𝐻 is the enthalpy of the sample; ∆𝐻𝛼 and ∆𝐻𝛽 are the melting enthalpies of a 100% crystalline 
sample in the α- and β-phase; and the 𝑥 and 𝑦 the amount of the α- and β-phase present in the 
sample, respectively, that are obtained from the FTIR measurements [34]. 
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3.6 EXTRACTION OF HUMAN MESENCHYMAL STEM CELLS AND PRIMARY CULTURE 
3.6.1 Human bone marrow sample extraction 
Human bone marrow was collected by the “Servicio de Hematología y Hemoterapia” in the 
Hospital La Fe, València. This procedure was performed according to established protocols after 
informed approval of the Local Ethics Committee of the Hospital La Fe. 
The extraction of peripheral blood mononucleated cells (PBMC’s) of BM was performed by 
ficoll density gradient centrifugation, which is explained below. 
 
3.6.2 Density gradient centrifugation 
The BM sample is diluted with DMEM (Dulbecco’s Modified Eagle’s Medium) (ThermoFisher) 
in proportion 1:2. After, 3 mL of Histopaque®-1077 (Sigma-Aldrich) were added to the sample and 
this moisture was centrifuged at 1000 g for 25 min at RT. At the end, the PBMC’s at the interphase 
were collected by aspiration with a Pasteur pipette (Figure 3.2). The cells are then washed two times 
in DMEM by centrifuging them at 400 g for 10 min each. 
Finally, the PBMC’s were diluted on DMEM with 10% fetal bovine serum (FBS, South America 
PREMIUM, Labclinic, Biowest) and counted. Cells are then seeded on T 25 cm2 (Becton Dickinson) 
flasks with DMEM culture media composed with 10% FBS, 100 U.mL-1 penicillin-streptomycin (P/S) 
(Invitrogen) and 2.5 mg.L-1 anfotericin B (Sigma Aldrich) at 37 ºC in a 95% humidified air containing 
5% CO2. 
After 48 h, the medium is changed and non-adherent cells are discarded. 
 
3.6.3 Primary human mesenchymal stem cells culture 
This method relies on the ability of hMSC’s to adhere on plastic between 24-48 h, in contrast 
to the HSC’s that also exist on the PBMC’s “mix” (Figure 3.2) [128]. After this time (48 h), the non-
adherent cells are discarded when the medium is changed. The next medium changes are performed 
every 4 days. 
When 90% of confluence is reached, cells are tripsinized with tripsin supplemented with 0.25 % 
of EDTA (Thermofisher) for 8 min. Then, tripsin is neutralized with DMEM (10% FBS) in proportion 1:2 
and it’s finally centrifuged at 400 g for 10 min. The supernatant is discarded and the pellet (where 
30 
 
the cells are) is diluted in DMEM (10% FBS). Cells are then counted and seeded on new T25 cm2 flasks, 
performing a new passage. 
 
 
Figure 3.2 – Isolation of hMSC’s from a BM biopsy. The whole BM is centrifuged and the mononucleated cells are separated 
from the red blood cells by ficoll gradient centrifugation. Then, the hMSC’s are separated from the other mononucleated 
cells (lymphocytes or monocytes) by plastic adherence in culture [128]. 
 
3.7 CELL CULTURE CONDITIONS 
The hMSC’s were seeded in T75 cm2 flasks (Becton Dickinson) with DMEM containing 1 g.L-1 
glucose supplemented with 0.5% amphotericin B, 1% P/S and 10% of FBS at 37 ºC in a 95% humidified 
air containing 5% CO2. The medium was changed every 3 days. 
For cell culture, 10 mg of microspheres obtained by electrospray (7% w/v) and treated with 
fibronectin were placed in a 2 mL eppendorf. Then, after FN adsorption, the cells were mixed with the 
microspheres (1x105 cells/eppendorf). Cell pellets without any microspheres were used as reference 
(positive control). Also, a density of 1x104 cells/well was seeded onto each one of the films (β-PVDF 
films and PVDF films with high and low microspheres concentration). The medium was changed every 
3 days. Cells were kept under expansion medium until confluence was reached. 
The cells that were not used immediately in experiments were placed in cryovials (Thermo 
Scientific) and frozen in liquid nitrogen with FBS supplemented with 10% dimethyl sulfoxide (DMSO) 
after tripsinization and centrifugation at 400 g for 5 min. 
Additionally, a differentiation culture media (osteogenic medium) was introduced after the 
hMSC’s reached 100% confluence on the biomaterials. It was composed of DMEM medium containing 
1 g.L-1 glucose supplemented with 0.5% anfotericin B, 1% P/S, 10% FBS, 8 mM of β-Glycerophosphate 
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disodium salt hydrate (Sigma Aldrich), 10 nM of dexamethasone-water soluble (Sigma Aldrich) and 
50 μg.mL-1 of L-Ascorbic acid 2-phosphate sesquimagnesium salt hydrate (Sigma Aldrich). The cell 
culture medium was replaced every 3 days during 14 days. 
 
3.8 STUDY OF CELL VIABILITY 
For quantification of viable cells in proliferation, after 4 days of cell seeding 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay was 
carried out. The method is based on the reduction of MTS tetrazolium compound by 
NAD(P)H-dependent dehydrogenase enzymes in metabolically active cells to generate a colored 
formazan product that is soluble in cell culture media which can be quantified measuring the 
absorbance, therefore reflecting the number of viable cells. 
Thus, cells were incubated with a 5:1 proportion of MTS (Promega) to DMEM without phenol 
red (ThermoFisher) for 3 h at 37 ºC in dark. Then, the supernatant was used to determine the 
absorbance at 570 nm. For this study, only MTS+DMEM without phenol red was used as reference 
(blank) and cells cultured in 12 mm glass coverslips were considered to be the positive control. 
All the quantitative results will be presented as mean ± standard deviation (SD) of triplicate 
samples. Statistical differences were determined by ANOVA using Tukey test for the evaluation of 
different groups (Graphpad Prism 5.0, GraphPad Software). p values < 0.05 were considered to be 
statistically significant. 
 
3.9 STUDY OF CELLS ADHESION 
At the fourth day of culture, cells focal adhesions on the microspheres were accessed by 
immunocytochemistry methods. First, the cells were washed in DPBS and fixed with formalin (Sigma 
Aldrich) at 4 ºC for 1 h. After, they were permeabilized with 0.5% Triton X-100 (Sigma Aldrich) in DPBS 
during 5 min at RT. After washing the samples with DBPS ++ (+calcium, +magnesium) (Sigma Aldrich), 
a protein solution of 5% bovine serum albumin (BSA) (Sigma Aldrich) and 0.1% Triton X-100 in DPBS 
was added. After 1 h at RT, the solution was removed and the samples were incubated with Anti-
Vinculin antibody (Sigma Aldrich) at a 1:400 dilution in a solution of 5% BSA and 0.1% Triton X-100 in 
DPBS during 1 h at 37 ºC. Then, the primary antibody was removed and the samples were washed 
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with 0.1% Triton X-100 in DPBS ++. At this point, samples were incubated with the secondary antibody 
antimouse Cy3 (Jackson Research), at a 1:200 dilution, together with Alexa Fluor® 488 phalloidin 
(Invitrogen), at a 1:100 dilution in the previously termed BSA solution during 1 h at 37 ºC. Finally, the 
solution was removed and the samples were once again washed in 0.1% Triton X-100 in DPBS++ 
before being mounted in a microscope slide with aqueous mounting medium containing DAPI (Vector 
Laboratories).  
For this study, cells cultured in 12 mm glass coverslips were used as a reference. Cell’s focal 
adhesions were visualized using a confocal microscope (DMi8, Leica) and ImageJ, Photoshop and 
Leica Application Suite X softwares were used for treatment and analysis of the obtained images. 
 
3.10 STUDY OF CELLS MORPHOLOGY 
After 4 days of cells proliferation and at the day 14 of osteogenic medium introduction, the 
samples were fixed with formalin as described before. Following, the samples were washed in 
phosphate buffer (PB) (ThermoFisher) before being incubated with 1% osmium tetraoxide (Aname) in 
PB for 45 min in dark. Then, the biomaterials were again washed to assure total removal of osmium 
tetraoxide, before being dehydrated through a graded series of alcohol (50%, 60%, 70%, 80%, 96% and 
100%) and submitted to critical-point drying (E3000, Polaron). The microspheres samples were before 
dispersed in 3% agarose (Sigma Aldrich) in water, making them suitable for critical-point drying 
procedure. 
The dried samples were coated with a gold layer using a sputter coating (EM MED020, Leica) 
and their morphology was observed by SEM (JSM6300, JEOL), with an accelerating voltage of 10 kV. 
 
3.11 FLOW CYTOMETRY STUDY 
As mentioned, flow cytometry (FC) is the most employed method to MSC’s identification and 
characterization. Therefore, this technique was employed in this work. 
FC is a laser-based technique that measures and analyses diverse parameters of single 
particles, normally cells (e.g. particle’s relative size, relative granularity or internal complexity, and 
relative fluorescence intensity), by suspending them in a stream of fluid. Then, this fluid transports the 
particles into a beam of light and, formerly, the optical system will distribute the light signals to 
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appropriate detectors. Finally, this will be transformed to electronic signals that can be computer 
processed. In this technique, the appropriate size ranges from 0.2 to 150 μm for any suspended 
particle or cell [129]. 
Therefore, before cell seeding onto the biomaterials, the freshly obtained and expanded 
hMSC’s were characterized by FC in a FACSCanto-II cytometer (Becton Dickinson, San Jose, CA, USA). 
First, the cells were separated in 3 centrifuge tubes and centrifuged at 1400 rpm for 10 min. Then, 
the supernatant was removed and the pellet was resuspended in 80 μL of phosphate-buffered saline 
(PBS) (ThermoFisher). Next, 20 μL of FcR Blocking Reagent (Miltenyl Biotec) was added to each one 
of the tubes and the cell-surface antigens were marked with anti-human antibodies according to Table 
3.1 in an incubation process that lasted 30 min at 2-8 ºC in dark. 
 
Table 3.1 – Antibodies used against cell-surface antigens to characterize hMSC’s. FITC - Fluorescein isothiocyanate; PE – 
Phycoerythrin; PerCP-Cy5.5 – Peridinin-chlorophyll protein-cyanine5.5; APC – Allophycocyanin.   
For each biomaterial 
sample… 
FITC PE PerCP-Cy5.5 APC 
Set 1 
CD90 
(Miltenyl Biotec) 
CD105 
(Miltenyl Biotec) 
HLA-DR 
(Becton Dickinson) 
CD73 
(Miltenyl Biotec) 
Set 2 
CD19 
(Becton Dickinson) 
CD34 
(Becton Dickinson) 
CD45 
(Becton Dickinson) 
CD14 
(Becton Dickinson) 
Control No antibodies added 
 
Succeeding, 2 mL of PBS was added to the tubes, before a 5 min centrifugation at 1400 rpm. 
The supernatant was removed and the cells were finally resuspended in 400 μL of PBS. Approximately 
50.000 labelled cells were acquired and data was subsequently analyzed using Infinicyt™ software 
(Cytognos S.L., Salamanca, Spain). 
To analyze how the hMSC’s markers evolve with time, cells that were cultured on the 
biomaterials were submitted to FC at day 4 of culture (when reaching 90% confluence) and at day 14, 
after differentiation medium introduction. With the purpose of having a suitable number of cells to 
perform FC analysis, biomaterials were cut in order to occupy all of the space in 6-well non-treated 
TCPS. Cells were seeded with the same density mentioned previously and, at the analysis day, they 
were tripsinized with 1 mL of tripsin for 5 min. Each one of the biomaterial-cultured cells were divided 
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in three groups and incubated with antibodies combinations according to Table 3.1. The following 
protocol was the same as described above for cells before seeding (day 0). Controls of cells seeded on 
TCPS were also submitted to FC analysis according to Table 3.2. 
 
Table 3.2 – Controls performed in flow cytometry analysis. The purpose of the controls at 7 and 14 days are to compare 
them to cells cultured on the PVDF samples, which are already growing under differentiation medium. 
Controls 
(done with) 
Day 4 Day 7 Day 14 
Expansion Medium    
Differentiation Medium    
 
3.12 OSTEOCALCIN IMMUNOCYTOCHEMISTRY 
Mineralization of bone is characterized by the expression of late markers of differentiation such 
as osteocalcin (OC) and osteopontin [59], as referred in section 1.4.2. Accordingly, after 14 days of 
culture in differentiation medium, the content of bone-specific OC was measured by 
immunocytochemistry methods.  
First, the cells were washed in DPBS and fixed with formalin at 4 ºC for 1 h. After, MSC’s were 
washed 3 times with DPBS ++ and permeabilized with 0.5% Triton X-100 in DPBS during 5 min at 
room temperature. After washing the samples with DBPS ++ (Sigma Aldrich), a protein solution of 5% 
BSA and 0.1% Triton X-100 in DPBS was added. After 30 min at 37 ºC, the solution was removed and 
the samples were incubated with Anti-Osteocalcin antibody (Abcam) at a 1:200 dilution in a solution 
of 5% BSA and 0.1% Triton X-100 in DPBS during 1 h at 37 ºC. Then, the primary antibody was removed 
and the samples were washed with 0.1% Triton X-100 in DPBS ++. At this point, the samples were 
incubated with the secondary goat antibody anti-rabbit Alexa 488® (Invitrogen), at a 1:200 dilution in 
the previously termed BSA solution during 1 h at 37 ºC. Finally, the solution was removed and the 
samples were once again washed in 0.1% Triton X-100 in DPBS++ before being mounted in a 
microscope slide with aqueous mounting medium containing DAPI.  
For this study, cells cultured in 12 mm glass coverslips were used as a reference. Cells relative 
content of OC was studied using a confocal microscope and ImageJ, Photoshop and Leica Application 
Suite X softwares were used for treatment and analysis of the obtained images. 
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4 RESULTS AND DISCUSSION 
4.1 ELECTROSPRAYED MICROSPHERES MORPHOLOGY AND SIZE DISTRIBUTION 
Previous studies have shown that with a polymer concentration of 5 % (w/v) till 10 % (w/v), 
microspheres with different size distributions are obtained, due to the solvent evaporation from the 
droplets before reaching the foil. That, together with polymer diffusion will generate dense and solid 
particles that end attached to the collector [124], [130]. 
Therefore, for PVDF electrospray at a concentration of 7% (w/v), spherical microspheres with 
diameters in a range between 0 – 6 μm were expected, when processed with the right parameters for 
achievement of PVDF microspheres by this technique, which were already studied by Correia et al. 
(2014) [124]. Figure 4.1 shows representative FESEM images of the PVDF microspheres and of the 
α-film adsorbed PVDF microspheres prepared by electrospray from a concentration of 7% (w/v) using 
DMF as solvent.  
 
Figure 4.1 – Morphology of the PVDF microspheres obtained. A) and B) Microspheres only; C) High density concentration 
of microspheres electrosprayed in α-PVDF film; D) Low density concentration of microspheres electrosprayed in α-PVDF 
film. Scales: A) 2 μm; B) 1 μm; C) 10 μm; D) 10 μm. 
A B 
C D 
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The spherical morphology of the obtained samples can be observed in Figure 4.1, along with 
a wide range for microspheres size. One thing that contributes to the microspheres surface roughness 
observed in Figure 4.1-A and B is the moisture present in the atmosphere when the electrospray is 
carried on, since the ambient parameters including temperature, humidity, and air velocity in the 
chamber contribute to different products of electrospray [131]. Indeed, mostly humidity and volatility 
of the solvent have shown to affect the surface of these products, showing submicron surface features 
with an increase in humidity [132]. 
The high and low concentration of PVDF microspheres adsorbed on films produced are shown 
in Figure 4.1-C and D, respectively. It can be seen that production of these biomaterials for cell seeding 
was successful, and the microspheres are within the same range of diameters.  
The corresponding particle size distribution is shown in Figure 4.2. The microspheres average 
diameter was 3.04 ± 1.70 μm. Each column within the figure is identified with the mean of the of size 
values that it encloses, e.g. between 0 and 1 μm, the column is identified with 0.5 μm, and so on. 
 
Figure 4.2 – Microspheres size distribution obtained for the described electrospray conditions. 
 
4.2 POLY(VINYLIDENEFLUORIDE) PHASE CONTENT 
In this work it was important to obtain the β- electroactive phase of PVDF, since it has shown 
very good results in cell culturing, as previously mentioned. 
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Also, as previously said, the characteristic FTIR bands of this polymer can provide an accurate 
confirmation that the β- electroactive phase was obtained, providing valuable information about the 
polymer phase structure [15]. It is known that PVDF is composed by the repetition unit –CH2–CF2– 
along the polymer chain; therefore, with FTIR, some vibrational modes can be useful for the phase’s 
identification. The characteristic FTIR absorption bands for α-, β- and γ-PVDF are represented in Table 
4.1. 
 
Table 4.1 – Characteristic absorption FTIR bands of different PVDF phases [15]. 
 α β γ 
Wavenumber (cm-1) 408 510 431 
 532 840 512 
 614 1279 776 
 766  812 
 795  833 
 855  840 
 976  1234 
 
Although some bands for the β- and γ-phase are very close to each other, it has been recently 
accepted that the band at 840 cm-1 is a strong band characteristic of the β-phase, whereas the 
characteristic absorption for the γ-phase appears as a shoulder at 833 cm-1 [15]. The α-phase has 
also a characteristic strong absorption band at 766 cm-1. Bormashenko et al. (2004) have summarized 
experimental and theoretical results for the vibrational spectrum of PVDF, being the band at 840 cm -1 
characteristic of the CH2 group rocking, and the band at 766 cm-1 of the CF2 group bending and of the 
scelete bending [133]. Figure 4.3 shows the FTIR-ATR spectra representative for PVDF microspheres 
and for the β-phase PVDF film for comparison. 
The general appearance of the spectra is similar for the two samples. However, for the 
microspheres, some characteristic absorption modes for the α-phase (766 and 976 cm-1) can be seen, 
along with the strong and characteristic band for β-phase at 840 cm-1, common for the two samples. 
The relative amount of α- and β-phase present in the different samples was calculated by 
eqn(1) as previously explained (section 3.5.2). The film presents a ≅ 76% fraction of β-phase, while 
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the microspheres present a ≅ 71%, which is even higher than the one obtained by Correia et al. (2014) 
[124]. This decrease in the percentage of the electroactive phase is according to the most pronounced 
α- absorption bands present in the microspheres spectrum. The achievement of the β-phase in these 
microspheres is due to the low temperature solvent evaporation, given that electrospray is done at 
room temperature, which favors polymer crystallization in the electroactive phase. Also, electrospinning 
has been characterized as a technique that due to high electric fields employed and high stretching 
ratio of the jets, can form the β-PVDF phase without the need of any treatment after this procedure 
[15], which can also be applied to electrospray, given that the conditions are nearly equal. 
 
 
Figure 4.3 – FTIR spectra of the β-phase PVDF film and microspheres. 
  
Comparatively to the previous Correia et al. (2014) [124] work with PVDF microspheres, there 
are no noteworthy differences. Although higher, the calculated value for the β-phase content of the 
microspheres is in the same interval of values and the characteristic bands of β- and α-phase PVDF 
present in the polymer microspheres spectra are very similar. 
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4.3 THERMAL CHARACTERIZATION 
Complementary to the infra-red measurements, DSC was performed in order to identify and 
quantify the crystalline phase of PVDF samples. Because α- and β-PVDF have similar melting 
temperatures, this technique is not used for differentiation between the two phases [31]. The 
characteristic peaks depend not only on the crystalline phase but also on the morphology of the 
polymer. Therefore, it was accepted a melting temperature range for the α- and β-phase PVDF, which 
is from 167 ºC to 172 ºC [15]. 
 The DSC thermogram obtained for the microspheres is represented in Figure 4.4. The samples 
show similar endothermic peaks. Comparing the microspheres to the PVDF film, the latter has higher 
melting enthalpy, which means that it contains higher crystallinity content.  
The degree of crystallinity of each sample was determined from the DSC curves using eqn(2) 
as previously described (section 3.5.3). The degree of crystallinity for the film was ≅ 58% and for the 
microspheres ≅ 52%, according to the thermograms. The melting temperature was about 167 ºC for 
the microspheres and 174 ºC for the film, values that fall within the established temperature range for 
β-phase PVDF, taking in account the equipment error. 
 
 
Figure 4.4 – DSC thermogram of the PVDF commercial film and of the PVDF microspheres obtained by electrospray 
method. 
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Comparing to the previous Correia et al. (2014) work with PVDF microspheres, there are no 
noteworthy differences in the melting temperature value neither in the degree of crystallinity [124]. 
 
4.4 CELL ATTACHMENT AND MORPHOLOGY 
The overall morphology of the hMSC’s seeded on the PVDF samples was visualized after 4 
days of cell culture by SEM (Figure 4.5). 
As said, FN was absorbed onto the biomaterials. This is a well-studied ECM glycoprotein able 
to bind to integrins, which are cell-surface receptors that link the ECM with the intracellular 
cytoskeleton [134]. Therefore, biomaterials surface modification with FN has already been performed 
and the results have shown to enhance cell attachment and proliferation [135]–[137]. Here, on Figure 
4.5 and Figure 4.6 it’s possible to see that, once more, FN enabled attachment and proliferation of 
cells seeded on the different PVDF biomaterials. 
SEM images can reveal that cells cultured on the microspheres films seem to elongate their 
adhesion points in order to find a suitable place to hold on to. In the film with high density of 
microspheres, the cells became thinner and their body becomes less flatten and more elongated, 
compared to the film with low density of microspheres (LD-M). Figure 4.5-A and Figure 4.5-B also show 
that the cells are able to attach not only with their elongated filopodia but also show adhesion within 
the cell body to the film and microspheres. As there is no visible film in Figure 4.5-C and Figure 4.5-D, 
the high density microspheres film (HD-M) resembles a 3D environment, where the cells can only 
attach to the agglomerates of microspheres. Because of that, hMSC’s adopt a particular shape, as can 
be seen. 
Cells were also cultured on the α-PVDF film, as this film is the one that was coated with 
electrosprayed microspheres for cell culture. It was important to verify the morphology adopted by 
hMSC’s on this film, since it could improve the prediction of the behavior of cells cultured in LD-M 
films. In Figure 4.5-E it is possible to verify that cells spread and flatten much more, compared to the 
films with microspheres. As there is no impediment on their growth, MSC’s adopt much larger shapes 
and have approximately twice the size.  
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Finally, cells cultured in the 3D environment can be seen in Figure 4.5-F. It is possible to 
observe some cells within the microspheres agglomerate. These cells have a much more spread and 
large body and shorter filopodia compared with the cells cultured on the other samples, which 
resembles more to an osteoblast morphology [138]. As microspheres form an agglomerate, cells seem 
100 μm 70 μm 
70 μm 100 μm 
200 μm 40 μm 
Figure 4.5 – Overall cell morphology of hMSC’s analyzed by SEM. A) and B) films with low density of PVDF microspheres; 
C) and D) films with high density of PVDF microspheres; E) alpha film; F) microspheres only. 
A B 
C D 
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to be continuously in contact with them, making this a suitable 3D environment for cell growth and 
culture. Additionally, microspheres have shown to break this agglomerate easily when submitted to low 
mechanical stress, so these may not confine cell growth or spreading. However, this substrate has its 
influence on cell shape: it’s possible to see that – compared to the films with microspheres – these 
cells have no need to elongate their filopodia towards an attachment point; that happens because they 
are already surrounded by an appropriate niche that gives them support to grow and spread effortlessly.  
Given this, it is possible to say that cells adopt diverse morphologies when cultured in the 
different substrates according to their surrounding niche. The “2 and a half” dimension substrate, 
which was considered to be the HD-M film, seemed to be similar to the 3D substrate, but it’s now 
possible to verify that the cells behave and grow in a different way when cultured on these two 
substrates.  
The overall cell attachment was also verified by confocal microscopy after actin-vinculin 
staining (Figure 4.6).  
In the control (cells seeded on glass), cells were able to attach perfectly, as can be seen by 
the red dots that represent the focal adhesions. Cells have flatten and spread their body due to the 
ability to create more focal adhesions to this substrate. 
Cells were also seeded on the β-PVDF film. This was carried out to evaluate differences of cell 
attachment and of cytoskeleton organization between the samples in the same piezoelectric 
conformational phase (β-phase), the flat film and the microspheres substrate, since this PVDF phase 
has proven to be the most suitable for cell culturing and differentiation [16], [33]. In this film it is 
possible to verify that there are cells that elongate more and seem to create specific adhesion points 
in the direction of cell growth, a fact that does not corroborate with cytoskeleton organization of the 
cells seeded on glass, meaning that substrate negative charge is influencing cell attachment, as seen 
in other studies done with stem cells seeded on flat β-phase films [122] 
In the microspheres films, as cells were not cultured in flat surfaces, the images had to be 
stacked and assembled according to the different focused plans. For this reason, in Figure 4.6-C and 
4.6-D focal adhesions are not as clear as seen in Figure 4.6-A and 4.6-B. However, their morphology 
is in concordance with the cytoskeleton orientation given that they adopt an elongated morphology, as 
seen in Figure 4.5. It is also possible to observe, in these both figures, focal adhesion points though 
the entire cell, indicating that cells are adhering to the microspheres. Additionally, their filopodia is 
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elongating towards the agglomerates of microspheres (according to Figure 4.5), in which it is possible 
to verify vinculin staining, creating very irregular shapes of hMSC’s.  
 
 
 
 
For the microspheres only, a 3D image was assembled with the stacks of photos taken in 
confocal microscope using ImageJ software (Figure 4.7). It is possible to verify that cells have a unique 
morphology, and that is due to the disordered nature of the microspheres which do not induce any 
preferential cells orientation. Their cytoskeleton is highly elongated, being this 3D assembly an 
agglomerate of cells and microspheres. As microspheres are much smaller when compared to the 
Figure 4.6 – Confocal fluorescence microscopy images of hMSC’s after 4 days of cell culture in A) glass covers, B) β-PVDF 
film C) films with high density of PVDF microspheres, D) films with low density of PVDF microspheres. The scale bar (100 
μm) is valid for all the images. 
A 
 
B 
 
C 
 
D 
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cells (Figure 4.5) and as they disrupt easily, it is not possible to observe them in this image. Also, these 
cells are smaller than the ones cultured in the other substrates and no vinculin staining can be seen. 
These two can be related with cell culture conditions, as medium changes always offer some 
mechanical stress to the seeded cells. This prevents cells to adhere to a specific set of microspheres 
and instead they are growing within dispersed groups of the substrate and adopting different 
morphologies, inhibiting focal adhesions.  
 
 
It has already been reported that disordered structures promotes MSC’s to undergo osteogenic 
differentiation and that mechanotransductive events between the cell and the biomaterial were a key 
factor influencing cell fate [139]. In concordance, a study demonstrated that increased contractility of 
hMSC’s leads preferentially to osteogenesis, while low contractility led to adipogenesis [140]. Matrix 
elasticity is also related to cell differentiation since Engler et al. (2006) showed that stiffer matrices 
increase cytoskeleton tension and thereby increase osteogenesis, while softer matrices led MSC’s to 
differentiate towards alternative lineages [141]. Additionally, hMSC’s that were allowed to grow without 
confinement demonstrated higher levels of bone cell markers when compared to those that grow under 
Figure 4.7 – Confocal fluorescence microscopy reconstructed 3D image of the hMSC’s after 4 days of cell culture on the 
β-PVDF microspheres. Each green cross is distanced 50 μm from the next one, as indicated by the scale bar. 
45 
 
standard culture conditions [142]. Through the years, 
researchers performed a series of studies which all 
demonstrated that cell culture conditions that increase 
cytoskeletal tension, promote osteogenesis; and other 
studies have linked cytoskeletal tension to cell 
spreading. Furthermore, McBeath et al. (2004) proved 
that changes in cell shape can alone influence in 
hMSC’s commitment between osteogenic and 
adipogenic differentiation, and that RhoA – a small 
GTPase known to regulate the actin cytoskeleton in the 
formation of stress fibers – and its downstream effector 
ROCK, when inhibited, decrease expression of osteogenic markers (Figure 4.8), being their activity 
greatest when cells are sub confluent in osteogenic media [138]. Summing up, cell shape can alter 
commitment of hMSC’s to adipocytes or osteocytes, given that adherent, flatten and spread cells 
undergo osteogenesis and round, non-spread cells undergo adipogenesis. 
Thus, looking at this work results for cell attachment and morphology, the LD-M film seems to 
be the one that can provide the greatest body cell spreading and adherence. Additionally, this may be 
the stiffer substrate, and consequently the one that promotes the most cytoskeleton tension, likely 
making this the most suitable substrate for osteogenic differentiation. Attending to the HD-M film, it is 
possible to verify that it shares some of these LD-M film features, however this substrate does not seem 
to have the characteristic LD-M film stiffness, being a substrate that cannot have flatten and spread 
cells, theoretically reducing osteogenic potential. 
As for the microspheres only, it can be seen that these cells can grow around the microspheres 
without having to remain attached and that they were able to create a 3D niche, which is the most 
suitable for mimicking in vivo bone marrow conditions of stem cell differentiation. Additionally, in Figure 
4.5-F it can be seen that these cells spread more when compared to the cells seeded on the other 
samples. Also, their small size and unlike morphology can be justified by cytoskeleton tension produced 
when cells grow between the microspheres. 
 
Figure 4.8 – Schematic representation of how cell 
shape and RhoA signaling or cytoskeletal tension 
alters hMSC’s commitment [138]. 
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4.5 CELL VIABILITY 
The viability of the attached cells on the PVDF samples after 4 days of culture is shown in 
Figure 4.9. This MTS assay has shown that PVDF is a suitable biomaterial for hMSC’s growth and 
survival, since the samples have a ≅ 400 % increase (film and microspheres films) and a ≅ 300% 
increase (microspheres only) in the measured absorbance compared to cells seeded on glass covers. 
There are not significant statistical differences among the PVDF samples. This result corroborates other 
cell studies that have been done with PVDF [16], [25], [26], [124].  
However, it is possible to verify a lower number of cells when seeded on the PVDF 
microspheres, with a huge standard deviation. This is may be due to cell culture conditions that can 
vary greatly with medium changes or to the microspheres agglomeration, given that higher 
agglomeration state may give the hMSC’s a more appropriate 3D culture niche, and consequently 
more cell viability. On other side, it has already been shown that proliferation is higher in flat surfaces 
than in 3D/porous ones. Additionally, it has been stated a genuine lack of proliferation ability of cells 
cultured in a 3D environment when comparing with those cultured in a monolayer [143].  
 
Figure 4.9 – Cell viability for cells seeded on the PVDF samples and cells seeded on glass covers (control +). Results are 
expressed as mean ± standard deviation with n = 3. *P ≤ 0.05, **P ≤ 0.01 vs. Glass. 
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4.6 FLOW CYTOMETRY ANALYSIS 
hMSC’s were submitted to FC in order to evaluate the loss or maintenance of the characteristic 
hMSC’s markers. 
In Figure 4.10, a histogram of the hMSC’s at passage 4 is represented. It’s possible to observe 
a logarithmic scale in the x-axis, which gives us an idea of the amount of antibodies that bound to the 
antigens of hMSC’s, meaning that curves are more advanced in the logarithmic scale as cells express 
more markers (CD’s). Each one of the 4 y-axis represent the antibodies (FITC, PE, PerCP and APC) 
used against the cell-surface antigens, as explained in Table 3.1. So, these cells revealed to be negative 
for hematopoietic markers CD19, CD34, CD45 and CD14, given that their blue representative curve 
is overlapping with the representative curve of the non-labeled cells, their autofluorescence, in green. 
These cells also revealed to be negative for HLA-DR and positive for CD90, CD105 and CD73, given 
that their pink curve is advanced in the “x” axis, when compared to the green curve of the non-labeled 
cells, which represents the positive labeling (Figure 4.10). So, according to Dominici et al. (2006) [58], 
these cells can be classified as mesenchymal stem cells. 
 
At day 4 of cell culture, hMSC’s were again analyzed. Now, cultured cells on the substrates 
were also evaluated. Due to the inability to separate hMSC’s from the microspheres, cells cultured on 
APC - CD73/14 
PerCP - HLA-DR/CD45 
FITC - CD90/19 
PE - CD105/34 
 hMSC’s CD90/105/HLA-DR/73 
 hMSC’s CD19/34/45/14 
 Non-labeled hMSC’s  
  
Figure 4.10 – Histograms of the hMSC’s (passage 4) flow cytometry analysis at day 0 of cell culture. 
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3D substrates could not pass through the cytometer fluidic system. Although microspheres were much 
smaller than hMSC’s, they form huge agglomerates, which can, by one side, disturb the fluidics system 
and on the other side cover the coupled antibody signal. For this reason, the FC analysis of hMSC’s 
cultured on 3D substrates has not been analyzed. 
First, the cells seeded for 4 days in TCPS (control +) were compared with day 0 of cells (Figure 
4.11-A). Then, day 4 of cells seeded on each one of the substrates (β-PVDF film, HD-M film and LD-M 
film) were also compared to day 4 of cells cultured in TCPS (Figure 4.11-B, 4.11-C and 4.11-D, 
respectively).  
 
When comparing cells before seeding and cells cultured on TCPS for 4 days (Figure 4.11-A), 
it can be observed that there was a great loss of CD90 and CD105. That is, the curves related to the 
CD90 
CD105 
CD73 
HLA-DR 
CD90 
CD105 
CD73 
HLA-DR 
CD90 
CD105 
CD73 
HLA-DR 
CD90 
CD105 
CD73 
HLA-DR 
A B 
C D
 Non-labeled hMSC’s day 4 
 Non-labeled hMSC’s day 0 
 hMSC’s CD90/105/HLA-DR/73 day 0 
 hMSC’s CD90/105/HLA-DR/73 TCPS day 4 
 hMSC’s CD90/105/HLA-DR/73 β-PVDF film day 4 
 hMSC’s CD90/105/HLA-DR/73 HD-M film day 4 
 hMSC’s CD90/105/HLA-DR/73 LD-M film day 4 
 
Figure 4.11 – Histograms of cells seeded in TCPS at day 4 compared to: A – day 0 cells before seeding; B – cells seeded 
on β-PVDF film at day 4; C – cells seeded on HD-M film at day 4; D – cells seeded on LD-M film at day 4. 
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positive markers of cells cultured on TCPS at day 4 (dark pink) are displaced from the curves related 
to the cells at day 0 (light green). The first are closer to the non-labelled cells (green), and therefore 
with less amount of CD90 and CD105 in their surface, given that the non-labeled cells (green) represent 
the autofluorescence of the cells, in other words, the negative labeling. 
In the same line of thought, CD73 also decreased expression but not as much as the other 
ones. As mentioned before, loss of these three hMSC’s markers together was already reported to be 
related with their differentiation [83], [84]. The difference in the behavior of CD105 and CD90 on the 
one side and CD73 on the other might be relevant. The loss of CD105 expression was already related 
to multi-lineage differentiation of stem cells. On the other hand, it has been stated that hMSC’s loss 
CD90 expression as cells mature towards osteoblastic-like cells [87]. Low down-regulation of CD73 
could be explained because it has already been shown that CD73 generated adenosine promotes 
osteoblast differentiation and that it is expressed in mature osteoblasts [144], [145], so its expression 
may vary, as seen in H. J. Jin et al. (2009) [83], but not as much as the other positive markers, maybe 
because more time is still needed for these cells to become totally differentiated. Thus, in 4 days of 
cell culture it can be observed that cells already started to lose some of the MSC markers, when 
comparing day 0 with day 4 cells cultured on TCPS’s, proving that cells have already started to 
differentiate. 
Now, cells cultured in TCPS for 4 days will be compared to cells cultured in the different 
produced materials (β-phase PVDF films, HD-M films and LD-M films) also for 4 days in order to verify 
if these biomaterials were able to enhance differentiation. 
Histogram B of Figure 4.11 demonstrates cells cultured on β-phase PVDF films. It can be seen 
that its positive markers are up-regulated in comparison to the day 4 control cells. That is, the curves 
related to the positive markers of cells cultured on β-phase PVDF films at day 4 (yellow) are displaced 
from the curves related to the cells cultured on TCPS at day 4 (dark pink). The first are more distant 
to the non-labelled cells (in light pink), and therefore with higher amount of CD90, CD105 and CD73 
in their surface, given that the non-labeled cells (light pink) represent the autofluorescence of the cells, 
in other words, the negative labeling. That happened because, upon acquisition of day 4 seeded cells 
on these substrates, there is a lot of autofluorescence of the sample, which can be seen in Figure 4.12 
(blue curves). This may happened because the cells used for this experiment were one passage ahead 
of those used to do the other FC studies on the samples. So, according to Wagner et al. (2008) this 
50 
 
phenomena can happen due to the accumulation of 
highly fluorescent lipofuscin at later passages and 
continuous increase in granularity and cell size, 
enhancing FC forward-scatter signal and increasing 
hMSC’s autofluorescence [146]. Conversely, it can 
be seen that CD73 has a “standard” 
autofluorescence (in blue – Figure 4.12), only CD90 
and CD105 increased it. So, according to CD90 and 
CD105 autofluorescence, cells loss almost totally 
these cell markers. However, it is not possible to support this conclusion, given that even the β-film 
autofluorescence histogram is up-regulated when compared to day 4 cells cultured on TCPS. 
Alternatively, this up-regulation can be a consequence of the material nature. Because this material 
has a superficial heterogeneous negative charge, it can be somehow influencing the mesenchymal 
stem cells and their labelling, having therefore consequences on FC analysis. 
Histograms C and D of Figure 4.11 represent cells seeded on HD-M films and LD-M films, 
respectively. It can be observed that their positive markers decreased even more compared to TCPS 
seeded cells at the same day, meaning that these cells lost a lot of their typical hMSC’s characteristics. 
This reports on the influence of these microspheres films on the differentiation of hMSC’s. Additionally, 
on histogram C of Figure 4.11, in CD105 and CD73, a sub-population of cells can be seen overlapping 
the non-labeled cells, meaning that these subset of cells lost completely their markers expression. As 
seen in Figure 4.9, cells did not lose their viability on these supports, proving that these sub-populations 
of cells are not relative to dead cells. Also, the decrease in CD90 was greater in cells cultured on this 
HD-M film. This leads to the conclusion that this substrate, and this irregular topography, somehow 
leads cells to differentiate, more that when cultured on more flat surfaces, which is disagreeing with 
the first theoretical hypothesis of the LD-M film being the most suitable for differentiation. 
Overall, it can be concluded that microspheres films, and particularly HD-M films give the cells 
the appropriate topography to induce their differentiation. Topography of biomaterials induces different 
cell shapes, and different shapes have shown to regulate indirectly differentiation onto the osteoblast 
phenotype [138]. Therefore, these substrates can be giving the cells a specific tension that directly 
stimulates osteoblastic differentiation.  
Figure 4.12 – Histogram of cells seeded in TCPS at day 
4 compared to β-PVDF film. The color legend is the same 
as Figure 4.11. 
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CD73 
HLA-DR 
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4.7 ASSESSMENT OF HUMAN MESENCHYMAL STEM CELLS OSTEOGENIC DIFFERENTIATION  
4.7.1 Flow Cytometry analysis 
After 4 days of cell proliferation under basal medium, osteogenic supplemented (OS) medium 
was added, as previously mentioned, and cells were kept in this medium for 14 days. Therefore, FC 
analysis was continued in order to compare these to the previously obtained results in basal medium. 
First, a check-up control was performed at day 7. Finally, at day 14 samples and controls were also 
analyzed. From now on, days will be describe as if day 0 was the first day of OS medium introduction. 
At day 7, two controls were analyzed and compared to day 4 TCPS seeded cells (before 
introducing OS medium). Both these controls were performed with cells cultured on TCPS, one with 
OS medium (Figure 4.13-B) and other with basal medium (Figure 4.13-A). 
 
Analyzing and comparing these histograms, it can be observed that, in OS medium, the 
markers were down-regulated when compared to basal medium, but not markedly, which means that 
OS medium is starting to make some influence on markers down-regulation. That is, the curves related 
to the positive markers of cells cultured on TCPS at day 7 with OS medium (green) are displaced from 
the curves related to the cells cultured on TCPS at day 4 (grey). The first are closer to the non-labelled 
A B 
CD90 
CD105 
CD73 
HLA-DR 
CD90 
CD105 
CD73 
HLA-DR 
 Non-labelled hMSC’s day 4 w/ basal medium 
 Non-labelled hMSC’s day 7 w/ basal medium 
 Non-labelled hMSC’s day 7 w/ OS medium 
 hMSC’s CD90/105/HLA-DR/73 day 7 w/ basal medium 
 hMSC’s CD90/105/HLA-DR/73 day 7 w/ OS medium 
 hMSC’s CD90/105/HLA-DR/73 day 4 w/ basal medium 
 
Figure 4.13 – Histograms of cells seeded on TCPS at day 7 compared to cells seeded on TCPS at day 4 before OS medium 
introduction. A – Cells seeded in basal medium; B – cells seeded in OS medium. 
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cells (red), and therefore with less amount of CD90, CD105 and CD73 in their surface, given that the 
non-labeled cells (red) represent the autofluorescence of the cells, in other words, the negative labeling. 
In the same line of thought, in histogram A of Figure 4.13, it can be seen that the curve related 
to CD90 of cells cultured on TCPS at day 7 with basal medium (yellow) was up-regulated when 
compared to the day 4 cells cultured on TCPS (grey), although CD105 and CD73 decreased 
expression, being closer to the non-labeled cells curve (blue). This differentiation study was done with 
a different subset of hMSC’s that, at day 0, had the typical hMSC’s markers but, as said, could have 
different sensibility to osteogenic medium or to the samples, and may have to be cultured for longer 
time to have the same results as those seen in Figure 4.11. However, these can be conclusive as well, 
because overall hMSC’s are losing their specific markers even without OS medium, which means that 
cell’s confluence achieved at the same time as medium change to OS had an influence on 
differentiation potential. 
 
For control purposes, another FC analysis was performed at 14 days after osteogenic induction 
comparing cells cultured on TCPS with and without OS medium with cells cultured on TCPS at day 4 
of cell culture without OS medium (Figure 4.14). 
It can be seen that CD105 and CD73 markers decreased with culture time on TCPS, even 
without OS and that, with addition of the inductive media, all of the markers decreased expression. 
That is, the curves related to CD105 and CD73 of cells cultured on TCPS at day 14 with (blue) and 
without (light green) OS medium are displaced from the curves related to the cells cultured on TCPS 
at day 4 (purple). The first are closer to the non-labelled cells (dark green), and therefore with less 
amount of CD105 and CD73 in their surface, that is, closer to the negative labeling. However, in basal 
medium, CD90 slightly increased its expression, as also seen at 7 days of culture (their positive curve, 
in light green, is farther to the non-labeled cells than the cells cultured on TCPS at day 4, in purple) 
(Figure 4.14). That can be due to the nature of the TCPS, which prevents cells to lose expression of all 
markers and enter osteogenic differentiation as fast as cells cultured with OS medium, which lose all 
expression markers, even in TCPS, as can be observed.  
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A final FC analysis was performed at day 14 of osteogenic induction comparing cells cultured 
on TCPS to cells cultured on the samples. All samples presented in Figure 4.15 were analyzed at day 
14 and all were induced to osteogenic differentiation upon addition of OS medium.  
Till now, FC has proven that the biomaterial had influence on hMSC’s markers, being down-
regulated when cultured in these substrates. Also, OS medium has shown to decrease these same 
markers and confluence has also revealed some influence on their loss of expression. 
Analyzing these graphs representing a 14 day culture, first it can be realized that non-labelled 
cells are up-regulated in all of them, being constant in β-phase PVDF film, compared to Figure 4.12. 
That is, the curves that correspond to the non-labeled cells cultured on the biomaterials, dark blue for 
the HD-M film, orange for the LD-M film and dark green for the β-phase film, are distanced from the 
non-labeled curve of cells cultured on TCPS (light pink), as if they have acquired labeling of CD90 and 
CD105, which is impossible. This supports the idea that autofluorescence increases in parallel with 
length of cell culture in these samples. This fact can also influence the analysis of the histograms, 
given that cells can be closer to loss of cell markers (closer to non-labelled cells curve) but still are on 
the same histogram place as cells cultured on TCPS, giving the illusion that these cells have not lost 
their pluripotentiality.  
CD90 
CD105 
CD73 
HLA-DR 
Non-labelled hMSC’s 14 days OS medium   
hMSC’s  CD90/105/HLA-DR/73 14 days OS medium  
hMSC’s  CD90/105/HLA-DR/73 14 days basal medium  
hMSC’s CD90/105/HLA-DR/73 4 days  
 
Figure 4.14 – Histograms TCPS seeded cells at day 14 compared to TCPS seeded cells at day 4 with and without OS 
medium. 
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It is noteworthy that here, histograms are comparing cells seeded on the biomaterials with the 
cells seeded on TCPS with the same days of culture, and not with the beginning of culture time nor 
with cells seeded with no OS.  
 
 
So, having a closer look, and ignoring the up-regulation on the non-labelled cells, in histogram 
A and B of Figure 4.15, HD-M and LD-M film, respectively, the substrates seem to have only a slightly 
down-regulation on CD105 and CD73 markers. This can mean that TCPS are also osteoinductive 
and/or that osteogenic supplements (biochemical signals) and confluence (mechanical stress) had 
influence the behavior, shape, adhesion and, consequently, differentiation of human mesenchymal 
stem cells, in a manner that could mimic the topographical stress created by HD-M and LD-M films 
only at four days without OS. Also, it can be concluded that the stress and tension created by the 
microspheres films at the first days of culture, which lead hMSC’s to lose expression of markers so 
fast, began to gain stability over time, and now it is clear that the difference is not so pronounced. 
C 
A B 
hMSC’s autofluorescence seeded in TCPS  
hMSC’s CD90/105/HLA-DR/73 seeded in TCPS  
hMSC’s autofluorescence seeded in HD-M film  
hMSC’s CD90/105/HLA-DR/73 seeded in HD-M film  
hMSC’s autofluorescence seeded in LD-M film  
hMSC’s CD90/105/HLA-DR/73 seeded in LD-M film  
hMSC’s autofluorescence seeded in β-film  
hMSC’s CD90/105/HLA-DR/73 seeded in  β-film  
 
Figure 4.15 – Histograms TCPS seeded cells at day 14 compared materials’ seeded cells at day 14. All samples and 
control were cultured with osteogenic medium. A – HD-M film; B – LD-M film; C – β-film. 
CD90 
CD105 
CD73 
HLA-DR 
CD90 
CD105 
CD73 
HLA-DR 
CD90 
CD105 
CD73 
HLA-DR 
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Besides, cells can present less down-regulation of markers, given that 4 days FC study was 
done with one subset of cells and the rest of the study was done with another set of unfrozen stem 
cells, but with origin on the same donor. It has been reported that hMSC’s age influence cell-based 
therapies [147]. So, even all of the experiments were done with cells from passages 4-6, they can 
behave differently. Also, culture conditions may not be the same, for example it is also known that 
initial plating density alone can influence call fate, independently of ahead transcriptional differentiation 
steps [138]. If cells are plated with high density, cell adhesion and spreading against the substrate 
decrease and cell-cell interaction increases. Although theoretically the same density was plated on 
PVDF substrates, manual cell counting call never be fully reliable. This also can happen because 
substrates are very irregular, particularly the HD-M film, and cells adopt different shapes and adhere 
differently even in the same substrate, influencing in this way FC analysis. 
Finally, in histogram C of Figure 4.15, the same that happened in four days of culture can be 
observed. The β-PVDF film seeded cells had so much autofluorescence in CD90 and CD105 markers 
that, when compared to the positive markers curve, can be deduced a total loss of CD105 and CD90. 
However, this is not an accurate conclusion. Additionally, this phenomena is not common, as can be 
seen in H. J. Jin et al. (2009) histograms, where isotype controls did not have autofluorescence. So, 
the same conclusions taken for day 4 seeded cells with no OS can be applied to this time point, which 
in summary appoint to the influence of the heterogeneous negative surface charge on the behavior 
and differentiation of these cells, consequently influencing FC analysis. This is a phenomenon that has 
to be explored in further studies, especially on what is the effect produced on the MSC’s by the 
superficial charge of these films. 
 
4.7.2 Osteocalcin localization by immunocytochemistry  
As said, osteocalcin is a major bone protein and has an important function in metabolism of 
mineralized tissues [148]. Therefore, to corroborate the results obtained by FC analysis, after 14 days 
of OS medium addition, an immunocytochemistry localization of osteocalcin was performed. The 
results for the different samples can be seen in Figure 4.16.  
First, it is clear that cells cultured on glass do not express osteocalcin (Figure 4.16-A). 
The β-phase PVDF film seems to have more osteocalcin staining when comparing to the 
microspheres films (Figure 4.16-B). This observation can lead to a different interpretation of the FC 
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results, since it is clear that these cells are expressing this major bone protein. So, it can be concluded 
that the autofluorescence phenomenon it’s covering the down-regulation of cell markers on these flat 
beta phase PVDF films.  
 
 
 
Comparing the two PVDF microspheres samples, they have almost the same amount of 
osteocalcin staining. The morphology can also be visualized through actin green staining. It is 
Figure 4.16 – Confocal fluorescence microscopy images of cells after 14 days of cell culture in: A) glass; B) β-PVDF film; 
C) HD-M PVDF film; D) LD-M PVDF film. The scale bar (100 μm) is valid for all images. 
A B 
C D 
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noteworthy that cells cultured on glass have a much more organized morphology, when compared to 
those cultured on PVDF samples, which seem to swirl. Also, in the HD-M film this effect seems 
enhanced, and that may be because cells are obligated to elongate and grow depending in where 
microspheres are placed. Given that these films have higher amounts of microspheres, cells do not 
have a flat surface to hold on and spread in parallel. So, even if FC studies at day 14 after OS 
introduction were doubtful, these results leave no place for it, confirming osteogenic differentiation by 
osteocalcin red staining.  
PVDF microspheres only were also observed by 
confocal microscopy in order to localize osteocalcin 
within the cells (Figure 4.17). As seen, cells still 
wrapped up on the microspheres. The cell number 
decreased a lot, probably due to mechanical stress and 
medium changes through all culture time. It has also 
been shown that BM MSC’s lack ability to proliferate in 
3D environments and, as culture time increases, the 
number of cells in deeper layers decreases [143]. 
Osteocalcin red staining can be observed even though 
actin stands out. So, although very instable, 3D culture 
on microspheres was able to show some osteocalcin 
staining. Even though this was a promising substrate to improve hMSC’s differentiation, further studies 
will have to be performed in order to find a reproducible way of culturing cells along with these 
microspheres for a long time. Also, a novel protocol for separation of microspheres and cells will be 
needed to perform FC analysis on these. 
Overall, PVDF samples show a soft osteocalcin staining, which along with FC analysis confirms 
the hypothesis that these cells are entering the osteogenic differentiation pathway. 
 
Figure 4.17 – Confocal fluorescence microscopy 
image of cells after 14 days of 3D cell culture on PVDF 
microspheres. 
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5 CONCLUSIONS, FINAL REMARKS & FUTURE PERSPECTIVES 
Concluding, this new shaped PVDF microspheres topography was able to enhance hMSC’s 
differentiation, proving the concept that morphology can really affect cell’s adherence, which will result 
in a different shape adopted by them, and consequently different predisposition to differentiate onto 
distinct lineages. Controversially, this effect was greater at the first 4 days of culture without addition 
of osteogenic supplements. This proves that the support itself has the appropriate features to induce 
this differentiation state and that, with appropriate stimulation, this effect could have been greater at 
14 days after osteogenic induction, instead of more stabilized, as seen. So, it can be concluded that 
mechanical signals or stress (provided by the substrate and by confluence itself) affects these hMSC’s 
even more than biochemical signals (osteogenic supplements introduced). 
Additionally, the negative heterogeneous charge has also affected the cells but in a different 
way. Even though cells seeded on β-phase PVDF films show greater staining on the osteocalcin 
immunocytochemistry, the FC analysis revealed an abnormal autofluorescence phenomena of the non-
labelled cells, which did not happen with the cells seeded on TCPS’s and happened at less extent with 
cells seeded on microspheres films. Additionally, this phenomenon happened only in two of the channel 
markers. Charge has already shown to influence stem cells behavior, but since this is a novel technique 
employed on the assessment of loss of cell markers to extrapolate differentiation potential, this has 
never been seen before. So, additional studies will have to be performed in order to understand what 
is really happening inside the cells, by evaluating downstream regulation of osteogenic transcription 
factors produced by external charge stimulation. 
Regarding microspheres 3D culture, it can be stated that a suitable culture niche for the cells 
– involved in microspheres – was created, as seen in the confocal images. The shape and morphology 
adopted by these cells did not resemble the ones seeded on the other substrates, but this fact does 
not refute the hypothesis of these cells entering osteogenic differentiation pathways. However, 
additional assays will have to be performed to confirm the possible osteoinductive potential of this 3D 
substrate, particularly a method for separation of microspheres and cells, in order to become suitable 
for a flow cytometry analysis, such as incorporating magnetic nanoparticles in the PVDF solution before 
electrospray processing. At day 4, no focal adhesions were observed and cell-cell interactions can 
increase with time, mimicking in vivo environments. Additionally, in order to have a more stable culture, 
different techniques for medium changes will also have to be established. Perfusion culture plates have 
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been introduced in the past few years can be an appropriate alternative for this type of culture, since 
the cell culture stability will be increased and mechanical disturbance provided by medium changes 
will be eliminated. 
Overall, since the β-PVDF phase is the one that has the highest piezoelectric proprieties, these 
cells could have an even more enhanced osteogenic response when cultured on electromechanically 
stimulated substrates, with a biorreator, which would result on a more biomimetic approach to these 
studies. This dynamic stimulation has already presented satisfactory results, as before reviewed.  
So, substrates with superficial charge as β-phase PVDF and substrates that expose cells to a 
different topography, like the films with microspheres produced in this work, can enhance cells 
osteogenic differentiation potential. Therefore, the produced scaffolds could be implanted directly to 
facilitate bone regeneration in vivo. With the mechanical stimulation produced by body’s natural 
movements, their piezoelectric response will be improved, and, consequently, this will give electric and 
mechanical stimulus to the cells, which together with biochemical stimulus, will increase tissue 
regeneration. 
Also, since flow cytometry is a method based on cells specific markers and the standard 
protocol has few steps for elaboration, washing steps and incubation hours are diminished, when 
comparing to immunocytochemistry methods. Moreover, manual management associated errors are 
not so frequent. This technique gives a quantitative reliable analysis of the hMSC’s-associated markers 
and how much these same markers lost expression. FC, till date, has not been used in assessment of 
differentiation potential of hMSC’s seeded on biomaterials, but it has proven to be a very powerful and 
valuable technique for these studies. Additionally, these studies could be improved with a flow 
cytometry analysis performed in shorter time intervals, demonstrating what is the evolution of markers 
with time and how they lose their expression when entering different phases of differentiation, which 
could help scientist understanding what the potential of their scaffolds/biomaterials. 
Summing up, the produced HD-M films have proven to be the most suitable for osteogenic 
differentiation. However, this same differentiation was achieved using the other produced biomaterials 
and a new technique was identified as valuable for these studies. 
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